46
1 WILFRED A. VAN DER DONK University of Illinois at Urbana-Champaign Department of Chemistry, 161 RAL Box 38-5 Urbana, IL 61801 Phone: (217) 244-5360; FAX: (217) 244-8533 [email protected] Date of birth April 21, 1966 US citizen since 2013 EDUCATION 1989 B.Sc & M.Sc, Leiden University, The Netherlands Thesis Advisor: Prof. Jan Reedijk Thesis Title: Model Complexes for Copper Metallo-Enzymes 1994 Ph.D., Rice University, Houston, Texas Thesis Advisor: Prof. Kevin Burgess Thesis Title: Transition Metal Catalyzed Hydroborations POSITIONS SINCE FINAL DEGREE 1994-1997 Postdoctoral Fellow, Massachusetts Institute of Technology, Cambridge, MA Advisor Prof. JoAnne Stubbe Project: Mechanistic Studies on Ribonucleotide Reductase 1997-2003 Assistant Professor, Department of Chemistry University of Illinois at Urbana-Champaign 2003-2005 Associate Professor, Department of Chemistry University of Illinois at Urbana-Champaign 2005-2008 William H. and Janet Lycan Professor of Chemistry University of Illinois at Urbana-Champaign 2008-present Richard E. Heckert Endowed Chair in Chemistry University of Illinois at Urbana-Champaign 2008-present Investigator, Howard Hughes Medical Institute 2007-present Professor, Institute for Genomic Biology University of Illinois at Urbana-Champaign FELLOWSHIPS AND AWARDS 1989 Cum Laude Masters Thesis, Leiden University 1989-1993 Robert A. Welch Predoctoral Fellowship 1991, 1994 Harry B. Weiser Scholarship for Excellence in Research (Rice University) 1994-1997 Postdoctoral Fellowship, Jane Coffin Childs Foundation for Medical Research 1997 Camille and Henry Dreyfus New Faculty Award 1998 Burroughs-Wellcome New Investigator in the Pharmacological Sciences 1998 Research Innovation Award from the Research Corporation

WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

1

WILFRED A. VAN DER DONK University of Illinois at Urbana-Champaign

Department of Chemistry, 161 RAL Box 38-5 Urbana, IL 61801

Phone: (217) 244-5360; FAX: (217) 244-8533 [email protected]

Date of birth April 21, 1966 US citizen since 2013

EDUCATION 1989 B.Sc & M.Sc, Leiden University, The Netherlands Thesis Advisor: Prof. Jan Reedijk Thesis Title: Model Complexes for Copper Metallo-Enzymes 1994 Ph.D., Rice University, Houston, Texas Thesis Advisor: Prof. Kevin Burgess Thesis Title: Transition Metal Catalyzed Hydroborations POSITIONS SINCE FINAL DEGREE 1994-1997 Postdoctoral Fellow, Massachusetts Institute of Technology, Cambridge, MA Advisor Prof. JoAnne Stubbe Project: Mechanistic Studies on Ribonucleotide Reductase 1997-2003 Assistant Professor, Department of Chemistry University of Illinois at Urbana-Champaign 2003-2005 Associate Professor, Department of Chemistry University of Illinois at Urbana-Champaign 2005-2008 William H. and Janet Lycan Professor of Chemistry University of Illinois at Urbana-Champaign 2008-present Richard E. Heckert Endowed Chair in Chemistry University of Illinois at Urbana-Champaign 2008-present Investigator, Howard Hughes Medical Institute 2007-present Professor, Institute for Genomic Biology University of Illinois at Urbana-Champaign FELLOWSHIPS AND AWARDS 1989 Cum Laude Masters Thesis, Leiden University 1989-1993 Robert A. Welch Predoctoral Fellowship 1991, 1994 Harry B. Weiser Scholarship for Excellence in Research (Rice University) 1994-1997 Postdoctoral Fellowship, Jane Coffin Childs Foundation for Medical Research 1997 Camille and Henry Dreyfus New Faculty Award 1998 Burroughs-Wellcome New Investigator in the Pharmacological Sciences 1998 Research Innovation Award from the Research Corporation

Page 2: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

2

1999 School of Chemical Sciences Teaching Award (U. Illinois) 1999 UIUC Research Board Beckman Award 1999 Arnold and Mabel Beckman Young Investigator Award 1999 3M Non-Tenured Faculty Award 2000 Cottrell Scholar of the Research Corporation 2001 Beckman Fellow, Center for Advanced Study, University of Illinois 2001 Alfred P. Sloan Fellowship 2002 Camille Dreyfus Teacher-Scholar Award 2003 Helen Corley Petit Scholar 2004 Pfizer Award, American Chemical Society, Division of Biological Chemistry 2004 University Scholar, UIUC 2006 Cope Scholar Award, American Chemical Society 2007 Tetrahedron Young Investigator Award in Bioorganic & Medicinal Chemistry 2008 School of Chemical Sciences Teaching Award (U. Illinois) 2009 Organic and Biomolecular Chemistry Lecture Award, Royal Society of Chemistry 2010 Jeremy Knowles Award, Royal Society of Chemistry 2010 Fellow of the Royal Society of Chemistry 2011 Fellow of the American Academy of Microbiology 2012 Fellow of the American Association for the Advancement of Science 2013 Emil Thomas Kaiser Award, The Protein Society 2014 Member of the American Academy of Arts and Sciences 2015 Bioorganic Chemistry Award, the Royal Society of Chemistry 2016 NIGMS Merit Award 2017 Repligen Award, American Chemical Society 2017 Vincent du Vigneaud Award, American Peptide Society SPECIAL LECTURES & SYMPOSIA Schneller Frontiers lecture, Auburn University, November 14, 2019 Rowena Matthews lecture, University of Michigan, September 24, 2019 David Hopwood lecture, John Innes Centre, UK, November 27, 2018 H.H. King lecture, Kansas State University, November 9, 2018 John Daly lecture, National Institutes of Health, October 26, 2018 Myron and Muriel Bender lectures, Northwestern University, August 6-7, 2018 J. Clarence Karcher lecture, University of Oklahoma, December 8, 2017 Backer lecture, University of Groningen, the Netherlands, October 30, 2017 Albert Hofmann award lecture, University of Zürich, October 24, 2017 Nozaki Memorial lecture, Duke University, Department of Biochemistry, December 2, 2016 Peter Yates Memorial lecture, University of Toronto, November 11, 2016 Plenary Lecture, International Conference on Circular Proteins, Brisbane, Australia, November 1, 2015 Andrew Braisted Lecture, UC Berkeley/UCSF. Oct 4, 2015 Novartis Lecture in Chemical Biology, Boston College, September 8, 2015 Frontiers in Chemistry Lectures, Texas A&M, April 6-8, 2015 Jerome A. Berson Lecture, Yale University, Department of Chemistry, March 3, 2015 CBI Program Symposium Keynote Lecturer, Harvard University, April 18-19, 2014 CBI Program Symposium Keynote Lecturer, University of Kansas, January 24, 2014 Genentech Lecture, The Scripps Research Institute, November 18, 2013 ACS Chem. Biol. Award Lecture 2013, ACS National Meeting, New Orleans, March 2013 Kharasch Visiting Professor, University of Chicago, January 2013

Page 3: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

3

GlaxoSmithKline lecture, Centre for Synthesis & Chemical Biology, Dublin, Ireland, December 14, 2012 T. T. Tchen Memorial Lecture, Wayne State University, September 28, 2012 Paul Dowd lecturer, University of Pittsburgh, May 2012 Chemistry Symposium, Boston University, June 24, 2011 Jeremy Knowles Lecture, Directing Biosynthesis II: Durham, UK, September 17, 2010 Organic and Biomolecular Chemistry Award Lecture, IUPAC Congress, Glasgow, August 7, 2009 Chemical Biology Symposium, SUNY Buffalo, September 2009 Novartis lecture, University of Michigan, May 19, 2008 CBIP Program Symposium Keynote Lecturer, Ohio State, May 8, 2007 Tetrahedron Young Investigator Award lecture, Berlin, June 28, 2007 Arthur C. Cope Scholar Award lecture, ACS meeting, August 2006 Baker Symposium on Chemical Biology, Cornell University, April 30, 2005 Pfizer Award lecture, ACS Meeting, August 2004 Science@theInterface Conference, University of Chicago, June 3, 2004 Wageningen Symposium on Organic Chemistry, the Netherlands, April 2004 Pfizer lecture in medicinal chemistry, University of Michigan, January 24, 2002 AFFILIATIONS American Chemical Society American Society for Biochemistry and Molecular Biology American Peptide Society American Society for Microbiology Society for Industrial Microbiology and Biotechnology The Protein Society Organic Chemistry Division of the American Chemical Society Biological Chemistry Division of the American Chemical Society Inorganic Chemistry Division of the American Chemical Society Society for the Advancement of Chicanos/Latinos and Native Americans in Science (SACNAS) Royal Society of Chemistry PROFESSIONAL ACTIVITIES UIUC P.I. and founding Director NIH Chemistry-Biology Interface Training Grant, 2004-2016 Faculty advisor, UIUC SACNAS chapter, founder, 2008-present Member, Sloan Scholarship Board, University Center for Exemplary Mentoring (UCEM) Director of Graduate Studies, Dept of Chemistry, 2012-present Carle-Illinois College of Medicine Research Advisory Board, July 2017-present Institute for Genomic Biology Advisory Committee, 2016-2018 Journal service Reviewing Editor, eLife, 2012-present Editorial Board Chemical Communications 2009-2011 Editorial Advisory Board J. Org. Chem. 2006-2018 Editorial Advisory Board ACS Chem. Biol. 2009-present Editorial Advisory Board ChemBioChem 2011-2016 Editorial Advisory Board, Chemical Communications 2012-present Editorial Advisory Board, ACS Central Science 2015-present Editorial Advisory Board, Cell Chemical Biology 2016-present

Page 4: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

4

Editorial Advisory Board, Chemical Reviews 2018-present Reviewer (2000-present) of manuscripts for Science, Nature, Nature Chem. Biol., Nat. Biotechnol., Nat. Chem., J. Am. Chem. Soc., Angew. Chem., Proc. Nat. Acad. Sci. USA, eLife, Nat. Commun., Biochemistry, Org. Lett., ACS Chem. Biol. ChemBioChem, Mol. Microbiol. J. Org. Chem., Inorg. Chem., Chem. Rev., Tetrahedron Lett., J. Phys. Chem., Bioorg. Med. Chem. Lett., BMC Microbiol., Appl. Environ. Microbiol. Guest editor, special issue of ChemComm on Enzymes and Proteins with Herbert Waldman Guest editor, special issue of Curr. Opin. Chem. Biol. with Squire Booker Guest editor, special issue of Curr. Opin. Chem. Biol. 2016 with Dan Tawfik Guest editor, special issue of Chem. Rev. 2017 on unusual enzymes in natural product biosynthesis Guest editor, special issue of J. Org. Chem. 2018 on natural product synthesis and biosynthesis Co-editor, “Cyclic Peptides: from Bioorganic Synthesis to Applications” Royal Society of Chemistry, Cambridge, UK, 2018. With James Naismith and Jesko Koehnke. Grant and fellowship review Member, NIH SBCB Synthetic and Biological Chemistry B study section. 2008-2012 Member, Scientific Advisory Committee, Damon Runyon Cancer Foundation 2008-2012 Member, Searle Scholars Advisory Board, 2017-2021 Member NIGMS Advisory Council, 2016-2018 Ad hoc member NIH Physical Biochemistry study section Ad hoc member NIH Bioorganic & Natural Products study section Ad hoc member NIH SBIR Drug Discovery and Development study section Ad hoc member NIH SBCB Synthetic and Biological Chemistry B study section Ad hoc member NIH Pioneer mail review Ad hoc member NIGMS Advisory Council, 2015-2016 Reviewer of grants for NIH, NSF, Research Corporation, Wellcome Fund, Dutch National Research Foundation (NWO), EPSRC (UK), Leverhulme Trust, NSERC, Science Foundation Ireland, and Petroleum Research Fund Conference organization, consulting, and scientific society service Co-chair symposium on vitamin B12 at the 3rd International Conference on Porphyrins and Phthalocyanines, held July 11-16, 2004, New Orleans Vice-chair, vitamin B12 Gordon Research Conference, Oxford, England, Sept 18-23, 2005 Chair vitamin B12 Gordon Research Conference, Biddeford, ME, July 1-6, 2007 Vice-chair, Bioorganic Chemistry Gordon Research Conference, Proctor Academy, June 10-15, 2007 Co-chair, Bioorganic Chemistry Gordon Research, Proctor Academy, June 15-20, 2008 Organizing Committee, 21st Enzyme Mechanisms Conference, Tucson, Arizona, January 3-6, 2009 Co-chair (with Jin Zhang UCSD), 2018 ASBMB national conference, San Diego, April 21-25, 2018 Chair, 27th Enzyme Mechanisms Conference, January 3-7, 2021. Organizing committee, 1st International Conference on RiPPs, April 23-25, Granada, Spain. Member Executive Committee, 2006-2009, Div. of Biological Chemistry, American Chemical Society Scientific Advisory Board, Divergence Inc., St. Louis, MO, 2004-2011 PUBLICATIONS CHRONOLOGICAL Independent Investigator (University of Illinois at Urbana-Champaign) *corresponding author Submitted

Page 5: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

5

290. Duan, Y.; Llorente, C.; Brand, K.; Chu, H.; Jiang, L.; Lang, S.; Torralba, M.; Shao, Y.; Liu, J.; Hernandez-Morales, A.; Lessor, L.; Rahman, I.R.; Miyamoto, Y.; Ly, M.; Sun, W.; Kiesel, R.; Hutmacher, F.; Lee, S.; Ventura-Cots, M.; Bosques-Padilla, F.; Verna, E.C.; Abraldes, J.G.; Brown Jr, R.S.; Vargas, V.; Altamirano, J.; Caballería, J.; Shawcross, D.; Ho, S.B.; Louvet, A.; Lucey, M.R.; Mathurin, P.; Garcia-Tsao, G.; Bataller, R.; Tu, X.M.; Eckmann, L.; van der Donk, W.A.; Young, R.; Trevor, L.; Pride, D.; Stärkel, P.; Fouts, D.E.; Schnabl, B.* “Bacteriophages That Target Cytolytic Enterococcus faecalis Reduce Features of Ethanol-induced Liver Disease”

289. Bothwell, I.R.; Cogan, D.P.; Kim, T.; Reinhardt, C.J.; van der Donk, W.A.*; Nair, S.K.* “Characterization of Glutamyl-tRNA Dependent Dehydratases using Non-Reactive Substrate Mimics”

288. Ting, C.; Funk, M.A.; Halaby, S.L.; Zhang, Z.; Gonen, T.; van der Donk, W.A.* “Use of a Scaffold Peptide in the Biosynthesis of Amino Acid Derived Natural Products”

Accepted for publication 287. Hegemann, J.D.; Shi, L.; Gross, M.L.*: van der Donk, W.A.* “Mechanistic Studies of the Kinase

Domains of Class IV Lanthipeptide Synthetases” ACS Chem. Biol. 2019. NIHMSID: 1034061 Published 286. Hegemann, J.D.; Bobeica, S.C.; Walker, M.C.; Bothwell, I.R.; van der Donk, W.A.* “Assessing

the Flexibility of the Prochlorosin 2.8 Scaffold for Bioengineering Applications” ACS Synth. Biol. 2019, 8, 1204-1214. PMCID: PMC6525029

285. Bobeica, S.C.; Dong, S.-H.; Huo, L.; 1, Mazo, N.; McLaughlin, M.I.; Jiménez-Osés, G.; Nair, S.K.*; van der Donk, W.A.* “Insights into AMS/PCAT Transporters from Biochemical and Structural Characterization of a Double Glycine Motif Protease” eLife, 2019; 8, e42305. PMCID: PMC6363468

284. Wu, C.; Biswas, S.; Garcia De Gonzalo, C.V.; van der Donk, W.A* “Investigations into the mechanism of action of sublancin” ACS Infect. Dis. 2019, 5, 454-459. PMCID: PMC6408254

283. Tang, W.; Bobeica, S.C.; Wang, L.; van der Donk* “CylA is a Sequence-Specific Protease Involved in Toxin Biosynthesis” J. Ind. Microbiol. Biotechnol. 2019, 46, 537-549. PMCID: PMC6450559

282. Bougioukou, D.J.; Ting, C.P.; Peck, S.C.; Mukherjee, S.; van der Donk, W.A.* “Use of the Dehydrophos Biosynthetic Enzymes to Prepare Antimicrobial Analogs of Alaphosphin” Org. Biomol. Chem. 2019, 17, 822-829. PMCID: PMC6344287

281. Funk, M.A.; Ting, C.; van der Donk, W.A.* “Catalytic Use of a Leader Peptide in the Biosynthesis of 3-Thia-glutamate” bioRxiv, 2018, 338681. DOI: 10.1101/338681.

280. Howe, G.W.; van der Donk, W.A.* “18O Kinetic Isotope Effects Reveal an Associative Transition State for Phosphite Dehydrogenase Catalyzed Phosphoryl Transfer” J. Am. Chem. Soc. 2018, 140, 17820-17824. PMCID: PMC6467793

279. Ren H.; Biswas, S.; Ho, S.; van der Donk, W.A.*; Zhao, H.* “Rapid Discovery of Glycocins through Pathway Refactoring in Escherichia coli” ACS Chem. Biol. 2018, 13, 2966-2972.

278. Si, T.; Tian, Q.; Min, Y.; Zhang, L.; Sweedler, J.; van der Donk, W.A.*; Zhao, H.* “Rapid screening of lanthipeptide analogs via in-colony removal of leader peptides in Escherichia coli” J. Am. Chem. Soc. 2018, 140, 11884-11888. PMCID: PMC6476326

277. Wang, K.K.A.; Ng, T.L.; Wang, P.; Huang, Z.; Balskus, E.P.*, van der Donk, W.A.* “Glutamic acid is a carrier for hydrazine during the biosyntheses of fosfazinomycin and kanamycin” Nat. Comm. 2018, 9, 3687. PMCID: PMC6133997

Page 6: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

6

276. An, L.; Cogan, D.P.; Navo, C.D.; Jiménez-Osés, G.; Nair, S.K.*; van der Donk, W.A.* “Substrate-assisted Enzymatic Formation of Lysinoalanine in Duramycin” Nat. Chem. Biol. 2018, 14, 28-933. PMCID: PMC6372306

275. Dutta, D.; Lai, K.-Y.; Reyes-Ordoñez, A.; Chen, J.; van der Donk, W.A* “Lanthionine Synthetase C-like Protein 2 (LanCL2) is Important for Adipogenic Differentiation” J. Lipid Res. 2018, 8, 1433-1445. PMCID: PMC6071776

274. McLaughlin, M.I.; van der Donk, W.A.* “Stereospecific Radical-mediated B12-dependent Methyl Transfer by the Fosfomycin Biosynthesis Enzyme Fom3” Biochemistry 2018, 57, 4967-4971. PMCID: PMC6103835

273. Hegemann, J.D.; Schwalen, C.J.; Mitchell, D.A.*; van der Donk, W.A.* “Elucidation of the Roles of Conserved Residues in the Biosynthesis of the Lasso Peptide Paeninodin” Chem. Comm. 2018, 54, 9007-9010. PMCID: PMC6092944

272. Bobeica, S.C.; van der Donk, W.A.* “The Enzymology of Prochlorosin Biosynthesis” Methods Enzymol. 2018, 604, 165-203.

271. Hegemann, J.D.; van der Donk, W.A.* “Investigation of Substrate Recognition and Biosynthesis in Class IV Lanthipeptide Systems” J. Am. Chem. Soc. 2018, 140, 5743-5754. PMCID: PMC5932250

270. Kakkar, N.; Perez, J.; Liu, W.R.; Jewett, M.; van der Donk, W.A.* “Incorporation of Nonproteinogenic Amino Acids in Class I and II Lantibiotics” ACS Chem. Biol. 2018, 20, 951-957. PMCID: PMC5910287

269. Hetrick, K.J.; Walker, M.C; van der Donk, W.A.* “Development and Application of Yeast and Phage Display of Diverse Lanthipeptides” ACS Cent. Sci. 2018, 4, 458–467. PMCID: PMC5920614

268. Koehnke, J.; Naismith, J.; van der Donk, W. A., Cyclic Peptides: from Bioorganic Synthesis to Applications. Royal Society of Chemistry: Cambridge, UK, 2018.

267. Ulrich, E.C.; Bougioukou, D.J.; van der Donk, W.A.* “Investigation of Amide Bond Formation during Dehydrophos Biosynthesis” ACS Chem. Biol. 2018, 13, 537-541. PMCID: PMC5856630

266. Yang, X.; Lennard, K.R.: He, C.; Walker, M.C.; Ball, A.T.; Doigneaux, C.; Tavassoli, A.*; van der Donk, W.A.* “A lanthipeptide library used to identify inhibitors of a protein-protein interaction inhibitor ” Nat. Chem. Biol. 2018, 14, 375-380. PMCID: PMC5866752

265. Repka, L.M.; Hetrick, K.J.; Chee, S.H.; van der Donk, W.A.* “Characterization of Leader Peptide Binding during Catalysis by the Nisin Dehydratase NisB” J. Am. Chem. Soc. 2018, 140, 4200-4203.

PMCID: PMC5901694 264. Zhang, Z.; Mahanta, N.; Hudson, G.A.; Mitchell, D.A.*; van der Donk, W.A.* “Mechanism of a

Class C Radical S-Adenosyl-L-methionine Thiazole Methyl Transferase” J. Am. Chem. Soc. 2017, 139, 18623-18631. PMCID: PMC5748327

263. Biswas, S.; Garcia De Gonzalo, C.V.; Repka, L.M.; van der Donk, W.A.* “Structure Activity Relationships of the S-linked Glycocin Sublancin” ACS Chem. Biol. 2017, 12, 2965-2969. PMCID: PMC5732038

262. Cogan, D.P.; Hudson, G.A.; Zhang, Z.; Pogorelov, T.V.; van der Donk, W.A.; Mitchell, D.A.; Nair, S.K.* “Mechanism of Enzymatic [4+2]-Aza-cycloaddition in Thiopeptide Antibiotic Biosynthesis” Proc. Natl. Acad. Sci. U.S.A. 2017, 114, 12928-12933. PMCID: PMC5724283

261. Born, D.A.; Ulrich, E.C.; Ju, K.-S.; Peck, S.C.; van der Donk, W.A.*; Drennan, C.L.* “Structural Basis for Methylphosphonate Biosynthesis” Science 2017, 358, 1336-1339. PMCID: PMC5901744

260. Funk, M.; van der Donk, W.A.* “Ribosomal Natural Products, Tailored to Fit” Acc. Chem. Res. 2017, 50, 1577-1586. PMCID: PMC5603336

Page 7: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

7

259. Cubillos-Ruiz, A.; Berta-Thompson, J.W.; Becker, J.W.; van der Donk, W.A.; Chisholm, S.W.* “Evolutionary Radiation of Lanthipeptides in Marine Cyanobacteria” Proc. Natl. Acad. Sci. U.S.A. 2017, 114, E5424-E5433. PMCID: PMC5502607

258. Burkhart, B.; Kakkar, N.; Hudson, G.; van der Donk, W.A.*; Mitchell, D.A.* “Chimeric Leader Peptides for the Generation of Non-Natural Hybrid RiPP Products” ACS Cent. Sci. 2017, 3, 629-638. PMCID: PMC5492250

257. Repka, L.M.; Chekan, J.R.; Satish K. Nair, S.K.*; van der Donk, W.A.* “Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes” Chem. Rev. 2017, 117, 5457-5520. PMCID: PMC5408752

256. Mahanta, N.; Zhang, Z.; Hudson, G.A.; van der Donk, W.A.;* Mitchell, D.A.* “Reconstitution and substrate specificity of the radical S-Adenosyl-methionine thiazole C-methyltransferase in thiomuracin biosynthesis” J. Am. Chem. Soc. 2017, 139, 4310-4313. PMCID:PMC5477235

255. Hetrick, K.J.; van der Donk, W.A.* “Ribosomally synthesized and post-translationally modified peptide natural product discovery in the genomic era” Curr. Opin. Chem. Biol. 2017, 38, 36-44. PMCID: PMC5474203

254. Peck, S.C.; van der Donk, W.A.* “Go It Alone: Four Electron Oxidations by Mononuclear Non‐heme Iron Enzymes” J. Biol. Inorg. Chem. 2017, 22, 381-394. PMCID:PMC5352498

253. Ortega, M.A.; Cogan, D.P.; Mukherjee, S.; Garg, N.; Li, B.; Maffioli, S.; Donadio, S.; Sosio, M.; Escano, J.; Smith, J.L.; Nair, S.K.*; van der Donk, W.A.* “Two flavoenzymes catalyze the post-translational generation of 5-chlorotryptophan and 2-aminovinyl-cysteine during NAI-107 biosynthesis” ACS Chem. Biol. 2017, 12, 548-557. PMCID: PMC5315687

252. Olivares, P.; Ulrich, E.C.; Chekan, J.R.; van der Donk, W.A.*; Nair, S.K.* “Characterization of Two Late-Stage Enzymes Involved in Fosfomycin Biosynthesis in Pseudomonads” ACS Chem. Biol. 2017, 12, 456-463. PMCID: PMC5315633

251. Peck, S.C.; Wang, C.; Dassama, L.M.K.; Zhang, B.; Guo, Y.; Rajakovich, L.J.; Bollinger, J.M.*; Krebs, C.*; van der Donk, W.A.* “O-H Activation by an Unexpected Ferryl Intermediate during Catalysis by 2-Hydroxyethylphosphonate Dioxygenase” J. Am. Chem. Soc. 2017, 139, 2045-2052. PMCID: PMC5302023

250. He, C.; Zeng, M.; Dutta, D.; Hee Koh, T.H.; Chen, J.*; van der Donk, W.A.* “LanCL proteins are not Involved in Lanthionine Synthesis in Mammals” Sci. Rep. 2017, 7, 40980. PMCID: PMC5247676

249. Huo, L.; Okesli, A.; Zhao, M.; van der Donk, W.A.* “Insights into the biosynthesis of duramycin” Appl. Environ. Microbiol. 2017, 83, e02698-16. PMCID: PMC5244291

248. Clark, K.M.; Tiang, S.; van der Donk, W.A.*; Lu, Y.* “Probing the Role of Backbone Carbonyl Interaction with the CuA Center in Azurin by Replacing the Peptide Bond with an Ester Linkage” Chem. Comm. 2017, 53, 224-227. PMCID: PMC5253137

247. Mukherjee, S.; Huo, L.; Thibodeaux, G.; van der Donk, W.A.* “Synthesis and Bioactivity of Diastereomers of the Virulence Lanthipeptide Cytolysin” Org. Lett. 2016, 18, 6188-6191. PMCID: PMC5269379

246. Zhang, Z.; Hudson, G.A.; Mahanta, N.; Tietz, J.I.; van der Donk, W.A.*; Mitchell, D.A.* “Biosynthetic timing and substrate specificity for the thiopeptide thiomuracin” J. Am. Chem. Soc. 2016, 138, 15511-15514. PMCID: PMC5148741

245. Ulrich, E.C.; van der Donk, W.A.* “Cameo appearances of aminoacyl-tRNA in natural product biosynthesis” Curr. Opin. Chem. Biol., 2016, 35, 29-36. PMCID: PMC5161580

244. Tang, W.; Thibodeaux, G.N.; van der Donk, W.A.* “The Enterococcal Cytolysin Synthetase Coevolves with Substrate for Stereoselective Lanthionine Synthesis” ACS Chem. Biol. 2016, 11, 2438-2446. PMCID: PMC5289929

Page 8: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

8

243. Thibodeaux, C.J.; Wagoner, J.; Yu, Y.; van der Donk, W.A.* “Leader Peptide Establishes Dehydration Order, Promotes Efficiency, and Ensures Fidelity During Lacticin 481 Biosynthesis” J. Am. Chem. Soc. 2016, 138, 6436-6444. PMCID: PMC4880487

242. Huo, L.; van der Donk, W.A.* “Discovery and characterization of bicereucin, an unusual D-amino acid-containing mixed two-component lantibiotic” J. Am. Chem. Soc. 2016, 138, 5254-5257. PMCID: PMC4851115

241. Huang, Z.; Wang, K.-K.A.; van der Donk, W.A.* “New Insights into the Biosynthesis of Fosfazinomycin” Chem. Sci. 2016, 7, 5219-5223. PMCID: PMC5215806

240. Garg, N.; Goto, Y.; Chen, T.; van der Donk, W.A.* “Characterization of the stereochemical configuration of lanthionine formation by the lanthipeptide synthetase GeoM” Biopolymers Pept. Sci. 2016, 106, 834–842. PMCID: PMC5108700

239. Ortega, M. A.; van der Donk, W.A.* “New Insights into the Biosynthetic Logic of Ribosomally Synthesized and Post-translationally Modified Peptide Natural Products” Cell Chem. Biol. 2016, 23, 31-44. PMCID: PMC4779184

238. Ding, W.; Liu, W.-Q.; Jia, Y.; Li, Y.; van der Donk, W.A.*; Zhang, Q.* “Biosynthetic investigation of phomopsins reveals a widespread pathway for ribosomal natural products in Ascomycetes” Proc. Natl. Acad. Sci. U.S.A. 2016, 113, 3521-3526. PMCID: PMC4822579

237. Ortega, M.A.; Hao, Y.; Walker, M.C.; Donadio, S.; Sosio, M.; Nair, S.K.;* van der Donk, W.A.* “Structure and tRNA Specificity of MibB, a Lantibiotic Dehydratase from Actinobacteria Involved in NAI-107 Biosynthesis” Cell Chem. Biol. 2016, 23, 370-380. PMCID: PMC4798866

236. Zhao, X.; van der Donk, W.A.* “Structural Characterization and Bioactivity Analysis of the Two-Component Lantibiotic Flv System from a Ruminant Bacterium” Cell Chem. Biol. 2016, 23, 246-256. PMCID: PMC4814930

235. Hudson, G.; Zhang, Z.; Tietz, J.; Mitchell, D.A.*; van der Donk, W.A.* “In vitro biosynthesis of the core scaffold of the thiopeptide thiomuracin” J. Am. Chem. Soc. 2015, 137, 16012-16015. PMCID: PMC4819586

234. Yang, X.: van der Donk, W.A.* “Posttranslational introduction of D-alanine into ribosomally synthesized peptides by the dehydroalanine reductase NpnJ” J. Am. Chem. Soc. 2015, 137, 12426-12429. PMCID: PMC4599312

233. Tang, W.; Dong, S.-H.; Repka, L.M.; He, C.; Nair, S.K.*; van der Donk, W.A.* “Applications of the Class II Lanthipeptide Protease LicP for Sequence-Specific, Traceless Peptide Bond Cleavage” Chem. Sci. 2015, 6, 6270-6279. PMCID: PMC5289929

232. Garcia De Gonzalo, C.V.; Denham, E.L.; Mars, R.A.T.; Stülke, J.; van der Donk, W.A.*; van Dijl, J.M.* “The Phosphoenolpyruvate:Sugar Phosphotransferase system is involved in sensitivity to the glucosylated bacteriocin sublancin” Antimicrob. Agents Chemother. 2015, 59, 6844-6854. PMCID: PMC4604375

231. Medema, M.H.*; Kottmann, R.; Yilmaz, P.; Cummings, M.; Biggins, J.B.; Blin, K.; de Bruijn, I.; Chooi. Y.H.; Claesen, J.; Coates, R.C.; Cruz-Morales, P.; Duddela, S.; Düsterhus, S.; Edwards, D.J.; Fewer, D.P.; Garg, N.; Geiger, C.; Gomez-Escribano, J.P.; Greule, A.; Hadjithomas, M.; Haines, A.S.; Helfrich, E.J.; Hillwig, M.L.; Ishida, K.; Jones, A.C.; Jones, C.S.; Jungmann, K.; Kegler, C.; Kim, H.U.; Kötter, P.; Krug, D.; Masschelein, J.; Melnik, A.V.; Mantovani, S.M.; Monroe, E.A.; Moore, M.; Moss, N.; Nützmann, H.W.; Pan, G.; Pati, A.; Petras, D; Reen, F.J.; Rosconi, F.; Rui, Z.; Tian, Z.; Tobias, N.J.; Tsunematsu, Y.; Wiemann, P.; Wyckoff, E.; Yan, X.; Yim, G.; Yu, F.; Xie, Y.; Aigle, B.; Apel, A.K.; Balibar, C.J.; Balskus, E.P.; Barona-Gómez, F.; Bechthold, A.; Bode, H.B.; Borriss, R.; Brady, S.F.; Brakhage, A.A.; Caffrey, P.; Cheng, Y.Q.; Clardy, J.; Cox, R.J.; De Mot, R.; Donadio, S.; Donia, M.S.; van der Donk, W.A.; Dorrestein, P.C.; Doyle, S.; Driessen, A.J.; Ehling-Schulz, M.; Entian, K.D.; Fischbach, M.A.; Gerwick, L.; Gerwick, W.H.; Gross, H.; Gust, B.; Hertweck, C.; Höfte, M.; Jensen, S.E.; Ju, J.; Katz, L.;

Page 9: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

9

Kaysser, L.; Klassen, J.L.; Keller, N.P.; Kormanec, J.; Kuipers, O.P.; Kuzuyama, T.; Kyrpides, N.C.; Kwon, H.J.; Lautru, S.; Lavigne, R.; Lee, C.Y.; Linquan, B.; Liu, X.; Liu, W.; Luzhetskyy, A.; Mahmud, T.; Mast, Y.; Méndez, C.; Metsä-Ketelä, M.; Micklefield, J.; Mitchell, D.A.; Moore, B.S.; Moreira, L.M.; Müller, R.; Neilan, B.A.; Nett, M.; Nielsen, J.; O'Gara, F.; Oikawa, H.; Osbourn, A.; Osburne, M.S.; Ostash, B.; Payne, S.M.; Pernodet, J.L.; Petricek, M.; Piel, J.; Ploux, O.; Raaijmakers, J.M.; Salas, J.A.; Schmitt, E.K.; Scott, B.; Seipke, R.F.; Shen, B.; Sherman, D.H.; Sivonen, K.; Smanski, M.J.; Sosio, M.; Stegmann, E.; Süssmuth, R.D.; Tahlan, K.; Thomas, C.M.; Tang, Y.; Truman, A.W.; Viaud, M.; Walton, J.D.; Walsh, C.T.; Weber, T.; van Wezel, G.P.; Wilkinson, B.; Willey, J.M.; Wohlleben, W.; Wright, G.D.; Ziemert, N.; Zhang, C.; Zotchev, S.B.; Breitling, R.; Takano, E.; Glöckner, F.O. “Minimum Information about a Biosynthetic Gene cluster” Nat. Chem. Biol. 2015, 11, 625-631.

230. Walker, M.; van der Donk, W.A.* “The Many Roles of Glutamate in Metabolism” J. Ind. Microbiol. Biotechnol. 2015, 43, 419-430. PMCID: PMC4753154

229. Zhu, H.; Peck, S.C.; Bonnot, F.; van der Donk, W.A.; Klinman, J.P.* “Oxygen-18 Kinetic Isotope Effects of Nonheme Iron Enzymes HEPD and MPnS Support Iron(III) Superoxide as the Hydrogen Abstraction Species” J. Am. Chem. Soc. 2015, 137, 10448-10451. PMCID: PMC4970508

228. Huang, Z.; van der Donk, W.A.* “An Unexpected Role for Ergothioneine” National Science Review 2015, 2, 382-383.

227. Dong, S.-H.; Tang, W.; Lukk, T.; Nair, S.K.*; van der Donk, W.A.* “The Enterococcal Cytolysin Synthetase Has an Unanticipated Lipid Kinase Fold” eLife 2015, 4:e07607. PMCID: PMC4550811

226. Ju, K.-S.; Gao, J.; Doroghazi, J.R.; Wang, K.K.A; Thibodeaux, C.J.; Li, S.; Metzger, E.; Fudala, J.; Su, J.; Zhang, J.; Lee, J.; Cioni, J.P.; Evans, B.S.; Hirota, R.; Labeda, D.P.; van der Donk, W.A.*; Metcalf, W.W.* “Discovery of Phosphonic Acid Natural Products by Genome Mining of 10,000 Actinomycetes” Proc. Natl. Acad. Sci. U.S.A. 2015, 112, 12175-12180. PMCID: PMC4593130

225. Bindman, N.A.; Bobeica, S.; Liu, W.R*; van der Donk, W.A.* “Facile Removal of Leader Peptides from Lanthipeptides by Incorporation of a Hydroxy Acid” J. Am. Chem. Soc. 2015, 137, 6975-6978. PMCID: PMC4505723

224. van der Donk, W.A. “Bacteria Do It Differently: An Alternative Path to Squalene” ACS Cent. Sci. 2015, 1, 64-65. PMCID: PMC4827487

223. Zhang, Q.; Doroghazi, J.R.; Zhao, X.; Walker, M.C.; van der Donk, W.A.* “Expanded natural product diversity revealed by analysis of lanthipeptide-like gene clusters in Actinobacteria” Appl. Environ. Microbiol. 2015, 81, 4339-4350. PMCID: PMC4475899

222. Yu, Y.; Mukherjee, S.; van der Donk, W.A.* “Product Formation by the Promiscuous Lanthipeptide Synthetase ProcM is under Kinetic Control” J. Am. Chem. Soc. 2015, 137, 5140-5148. PMCID: PMC4487812

221. Yang, X.; van der Donk, W.A.* “The Michael-type cyclizations in lantibiotic biosynthesis are reversible” ACS Chem. Biol. 2015, 10, 1234-1238. PMCID: PMC4433588

220. Peck, S.C.; Chekan, J.R.; Ulrich E.C.; Nair, S.K.; van der Donk, W.A.* “A Common Late-Stage Intermediate in Catalysis by 2-Hydroxyethyl-phosphonate Dioxygenase and Methylphosphonate Synthase” J. Am. Chem. Soc. 2015, 137, 3217-3220. PMCID: PMC4487810

219. Thibodeaux, G.N.; McClerren, A.L.; Ma, Y.; Gancayco, M.R.; van der Donk, W.A.* “Synergistic binding of the leader and core peptide by the lantibiotic synthetase HalM2” ACS Chem. Biol. 2015, 10, 970-977. PMCID: PMC4414810

218. Huang, Z.; Wang, K.-K.A.; Lee, J.; van der Donk, W.A.* “Biosynthesis of fosfazinomycin is a convergent process” Chem. Sci. 2015, 6, 1282-1287. PMCID: PMC4303578

217. Tang, W.; Jimenez-Oses, G.; Houk, K.N.*; van der Donk, W.A.* “Substrate Control in Stereoselective Lanthionine Biosynthesis” Nat. Chem. 2015, 7, 57-64. PMCID: PMC4270103

Page 10: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

10

216. Ortega, M.A.; Hao, Y.; Zhang, Q.; Walker, M.C.; van der Donk, W.A.*, Nair, S.K.* “Structure and Mechanism of the tRNA-Dependent Lantibiotic Dehydratase NisB” Nature, 2015, 517, 509-512. PMCID: PMC4430201

215. Thibodeaux, C.; Ha, T.; van der Donk, W.A.* “A Price to Pay for Relaxed Substrate Specificity: A Comparative Kinetic Analysis of the Class II Lanthipeptide Synthetases, ProcM and HalM2” J. Am. Chem. Soc., 2014, 136, 17513-17529. PMCID: PMC4277782

214. Zeng, M.; van der Donk, W.A.*; Chen, J.* “Lantibiotic C-like protein 2 (LanCL2) is a novel regulator of Akt” Mol. Biol. Cell, 2014, 25, 3954-3961. PMCID: PMC4244203

213. van der Donk, W.A.*; Nair, S.K.* “Structure and Mechanism of Lanthipeptide Biosynthetic Enzymes” Curr. Opin. Struct. Biol. 2014, 29, 58-66. PMCID: PMC4267917

212. Zhang, Q.; Yang, X.; Wang, H.; van der Donk, W.A.* “High divergence of the precursor peptides in combinatorial lanthipeptide biosynthesis” ACS Chem. Biol. 2014, 2686-2694. PMCID: PMC4245175

211. Huang, Y.; Reis, E.S.; Knerr, P.J.; van der Donk, W.A.; Ricklin, D.; Lambris, J.D.* “Conjugation to Albumin-Binding Molecule Tags as a Strategy to Improve Both Efficacy and Pharmacokinetic Properties of the Complement Inhibitor Compstatin” ChemMedChem 2014, 9, 2223-2226. PMCID: PMC4177305

210. Zhang, Q.; Ortega, M.A.; Shi, Y.; Wang, H.; Melby, J.O.; Tang, W.; Mitchell, D.A.; van der Donk, W.A.* “Structural investigation of ribosomally synthesized natural products by hypothetical structure enumeration and evaluation using tandem MS” Proc. Natl. Acad. Sci. U.S.A. 2014, 111, 12031-12036. PMCID: PMC4143002

209. Mukherjee, S.; van der Donk, W.A.* “Mechanistic Studies on the Substrate-Tolerant Lanthipeptide Synthetase ProcM” J. Am. Chem. Soc. 2014, 136, 10450-10459. PMCID: PMC4111213

208. Ortega, M.A.; Velásquez, J.E.; Garg, N.; Zhang, Q.; Joyce, R.E.; Nair, S.K.*; van der Donk, W.A.* “Substrate Specificity of the Lanthipeptide Peptidase ElxP and the Oxidoreductase ElxO” ACS Chem. Biol., 2014, 9, 1718-1725. PMCID: PMC4136673

207. Bindman, N. A; van der Donk, W.A.* RiPPs: Ribosomally Synthesized and Posttranslationally Modified Peptides. In Natural Products: Discourse, Diversity, and Design; Osbourn, A., Goss, R., Carter, G.T., Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2014; pp 197-217.

206. Ranaghan, K.E.; Hung, J.E.; Bartlett, G.J.; Mooibroek, T.J.; Harvey, J.N.; Woolfson, D.N.; van der Donk, W.A.*; Mulholland, A.J.* “A catalytic role for methionine revealed by a combination of computation and experiments on phosphite dehydrogenase” Chem. Sci. 2014, 5, 2191-2199.

205. Clark, K.M.; Yu, Y.; van der Donk, W.A.*; Blackburn, N.J.; Lu, Y.* “Modulating the Copper-Sulfur Interaction in Type 1 Blue Copper Azurin by Replacing Cys112 with Nonproteinogenic Homocysteine” Inorg. Chem. Front., 2014, 1, 153-158. PMCID: PMC3972132

204. Garcia De Gonzalo, C.V.; Zhu, L; Oman, T.J.; van der Donk, W.A.* “NMR structure of the S-linked glycopeptide sublancin 168” ACS Chem. Biol. 2014, 9, 796–801. PMCID: PMC3985867

203. Hung, J.; Fogle, E.J.; Garg, N.; Chekan, J.R.; Nair, S.K.; van der Donk, W.A.* “Chemical Rescue and Inhibition Studies to Determine the Role of Arg301 in Phosphite Dehydrogenase” PLoS One 2014, 9, e87134. PMCID: PMC3909101

202. Wang, H.; Oman, T.J.; Zhang, R.; Garcia De Gonzalo, C.V.; Zhang, Q.; van der Donk, W.A.* “The glycosyltransferase involved in thurandacin biosynthesis catalyzes both O- and S-glycosylation” J. Am. Chem. Soc. 2014, 136, 84-87. PMCID: PMC3913795

201. Gao, J.; Ju, K.S.; Yu, X.; Velásquez, J.E.; Mukherjee, S.; Lee, J.; Zhao, C.; Evans, B.S.; Doroghazi, J.R.; Metcalf, W.W.*; van der Donk, W.A.* “Use of a Phosphonate Methyltransferase in the Identification of the Fosfazinomycin Biosynthetic Gene Cluster” Angew. Chem. Intl. Ed. 2014, 53, 1334-1337. PMCID: PMC3927463

Page 11: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

11

200. Agarwal, V.A.; Peck, S.C.; Chen, J-H.; Borisova, S.A.; Chekan, J.R.; van der Donk, W.A.*; Nair, S.K.* “Structure and function of phosphonoacetaldehyde dehydrogenase: the missing link in phosphonoacetate biodegradation” Chem. Biol. 2014, 21, 125-135. PMCID: PMC4313731

199. Garg, N.; Oman, T.J.; Wang, T.-S. A.; Garcia De Gonzalo, C.V.; Walker, S.; van der Donk, W.A.* “Mode of Action and Structure-Activity Relationship Studies of Geobacillin I” J. Antibiot. 2014, 67, 133-136. special issue in honor of Christopher T. Walsh. PMCID: PMC4004768

198. Yu, Y.; Zhang, Q.; van der Donk, W.A.* “Insights into the Evolution of Lanthipeptide Biosynthesis” Protein Sci. 2013, 22, 1478-1489. Invited review for receiving the Kaiser award. PMCID: PMC3831664

197. Peck, S.P; van der Donk, W.A.* “Phosphonate Biosynthesis and Catabolism: A Treasure Trove of Unusual Enzymology” Curr. Opin. Chem. Biol. 2013, 17, 580-588. PMCID: PMC3764496

196. Bindman, N. A; van der Donk, W.A.* “A General Method for Fluorescent Labeling of the N-Termini of Lanthipeptides and Its Application to Visualize their Cellular Localization” J. Am. Chem. Soc. 2013, 135, 10362–10371. PMCID: PMC3775354

195. Bougioukou, D.J.; Mukherjee, S.; van der Donk, W.A.* “Revisiting the Biosynthesis of Dehydrophos Reveals a tRNA Dependent Pathway” Proc. Natl. Acad. Sci. USA 2013, 110, 10952-10957. PMCID: PMC3704017

194. Knerr, P.J.; van der Donk, W.A.* “Chemical Synthesis of the Lantibiotic Lacticin 481 Reveals the Importance of Lanthionine Stereochemistry” J. Am. Chem. Soc. 2013, 135, 7094-7097. PMCID: PMC3736828

193. Peck, S.C.; van der Donk, W.A.* “Biochemistry: Positive and Radical” Nature 2013, 496, 34-35. Commentary.

192. Evans, B.S.*; Zhao, C.; Gao, J.; Evans, C.M.; Ju, K.S.; Doroghazi, J.R.; van der Donk, W.A.; Kelleher, N.L.; Metcalf, W.W. “Discovery of the Antibiotic Phosacetamycin via a New Mass Spectrometry-Based Method for Phosphonic Acid Detection” ACS Chem. Biol. 2013, 8, 908-913. PMCID: PMC3657337

191. Garg, N.; Salazar-Ocampo, L.M.A.; van der Donk, W.A.* “In vitro activity of the Nisin Dehydratase NisB” Proc. Natl. Acad. Sci. USA 2013, 110, 7258-7263. PMCID: PMC3645518

190. Yang, X.; van der Donk, W.A.* “Ribosomally Synthesized and Post-Translationally Modified Peptide Natural Products: New Insights Into the Role of Leader and Core Peptides During Biosynthesis” Chem. Eur. J. 2013, 24, 7662-7677. PMCID: PMC3838977

189. Tang, W.; van der Donk, W.A.* “The Sequence of the Enterococcal Cytolysin Imparts Unusual Lanthionine Stereochemistry” Nat. Chem. Biol. 2013, 9, 157-159. PMCID: PMC3578037

188. Arnison, P. et al.; van der Donk, W.A.* “Ribosomally Synthesized and Post-Translationally Modified Peptide Natural Products: Overview and Recommendations for a Universal Nomenclature” Nat. Prod. Rep. 2013, 30, 108-160. PMCID: PMC3954855

187. Thibodeaux, C. J.; van der Donk, W.A.* “Converging on a mechanism for choline degradation” Proc. Natl. Acad. Sci. U.S.A., 2012, 52, 21184–21185. PMCID: PMC3535664

186. Zhang, Q.; Yu, Y.; Vélasquez, J. E.; van der Donk, W. A.* “Evolution of Lanthipeptide Synthetases” Proc. Natl. Acad. Sci. U.S.A., 2012, 109, 18361-18366. PMCID: PMC3494888

185. Shi, Y.: Bueno, A; van der Donk, W.A.* “Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli” Chem. Comm. 2012, 48, 10966-10968. PMCID: PMC3485686

184. Cooke, H.A.; Peck, S.C.; Evans, B.S.; van der Donk, W.A.* “Mechanistic Investigation of Methylphosphonate Synthase, a Non-Heme Iron-Dependent Oxygenase” J. Am.Chem. Soc., 2012, 134, 15660-15663. PMCID: PMC3458437

Page 12: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

12

183. Thibodeaux, G.; van der Donk, W.A.* “An engineered lantipeptide synthetase serves as a general leader peptide-dependent kinase” Chem. Comm. 2012, 48, 10615-10617. PMCID: PMC3475617

182. Knerr, P.J.; Oman, T.J.; Garcia de Gonzalo, C.; Lupoli,T.J. Walker S.; van der Donk, W. A.* “Non-Proteinogenic Amino Acids in Lacticin 481 Analogues Result in More Potent Inhibition of Peptidoglycan Transglycosylation” ACS Chem. Biol. 2012, 7, 1791-1795. PMCID: PMC3501146

181. Zhang, Q.; van der Donk, W.A.* “Catalytic promiscuity of a bacterial α-N-methyltransferase” FEBS Lett. 2012, 588, 3391-3397. PMCID: PMC3462432

180. Metcalf, W.W.*; Griffin, B.M.; Cicchillo, R.M.; Gao, J.; Janga, S.C.; Cooke, H.A.; Circello, B.T.; Evans; B.S.; Martens-Habbena, W.; Stahl, D.A.; van der Donk, W.A.* “Synthesis of methylphosphonic acid by abundant marine microbes: a source for methane in the aerobic ocean” Science 2012, 337, 1104-1107. PMCID: PMC3466329

179. Wang, H.; van der Donk, W.A.* “Biosynthesis of the Class III Lantipeptide Catenulipeptin” ACS Chem. Biol. 2012, 7, 1529-1535. PMCID: PMC3448297

178. Peck, S.C.; Gao, J.; van der Donk, W.A.* “Discovery and Biosynthesis of Phosphonate and Phosphinate Natural Products” Methods Enzymol. 2012, 516, 101-123 (special volume on natural product biosynthesis edited by Sir David Hopwood).

177. Zou, Y.; Zhang, H.; Brunzelle, J.S.; Johannes, T.W.; Woodyer, R.; Hung, J.E.; Nair, N.; van der Donk, W.A.; Zhao,

H.; Nair, S.K.* “Crystal Structures of Phosphite Dehydrogenase Provide

Insights into Nicotinamide Cofactor Regeneration” Biochemistry 2012, 51, 4263-4270. 176. Kim, S.Y.; Ju, K.-S.; Metcalf, W.W.; Evans, B.S.; Kuzuyama, T.; van der Donk, W.A.* “Different

Biosynthetic Pathways to Fosfomycin in Pseudomonas syringae and Streptomyces” Antimicrob. Agents Chemother. 2012, 56, 4175-4183. PMCID: PMC3421606

175. Knerr, P.J.; van der Donk, W. A.* “Chemical Synthesis and Biological Activity of Analogues of the Lantibiotic Epilancin 15X” J. Am. Chem. Soc. 2012, 134, 7648-7651. PMCID: PMC3349288

174. Hung, J.E.; Fogle, E.J.; Christman, H.D.; Johannes, T.W.; Zhao, H.; Metcalf, W.W.; van der Donk, W.A.* “Investigation of the Role of Arg301 Identified in the X-ray Structure of Phosphite Dehydrogenase” Biochemistry 2012, 51, 4254-4262. PMCID: PMC3361975

173. Tang, W.; van der Donk, W. A.* “Structural characterization of four prochlorosins: a novel class of lantipeptides produced by planktonic marine cyanobacteria” Biochemistry 2012, 51, 4271-4279. PMCID: PMC3361976 172. Garg, N.; Tang, W.; Goto, Y.; van der Donk, W.A.* “Lantibiotics from Geobacillus thermodenitrificans” Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 5241-5246. PMCID: PMC3325677 171. Oman, T.J.; Knerr, P.J.; Bindman, N.A.; Velásquez, J.E.; van der Donk, W.A.* “An Engineered

Lantibiotic Synthetase That Does Not Require a Leader Peptide on Its Substrate” J. Am. Chem. Soc. 2012, 134, 6952-6955. PMCID: PMC3350211

170. Knerr, P.J.; van der Donk, W.A.* “Discovery, Biosynthesis and Engineering of Lantipeptides” Ann. Rev. Biochem. 2012, 81, 479-505.

169. Peck, S.C.; Kim, S.Y.; Evans, B.S.; van der Donk, W.A.* “Stereochemistry of Hydride Transfer by Group III Alcohol Dehydrogenases Involved in Phosphonate Biosynthesis” Med. Chem. Commun. 2012, 3, 967-970. PMCID: PMC3764496 168. Zhang, Q.; van der Donk, W.A.* “Answers to the carbon-phosphorus lyase conundrum” ChemBioChem 2012, 13, 627-629. PMCID: PMC3206492 167. Zhang, Q.; van der Donk, W.A.*; Liu, W.* “Radical-mediated enzymatic methylation: a tale of two

SAMs” Acc. Chem. Res. 2011, 45, 555-564. PMCID: PMC3328197 166. Oman, T.O.; Lupoli, T.J.; Wang, T-S. A.; Kahne, D.; Walker, S.*; van der Donk, W.A.*

“Haloduracin Binds the Peptidoglycan Precursor Lipid II with 2:1 Stoichiometry” J. Am. Chem. Soc. 2011, 133, 17544-17547. PMCID: PMC3206492

Page 13: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

13

165. Agarwal, V.; Borisova, S.A.; Metcalf, W.W.; van der Donk, W.A.*; Nair, S.K. * “Structural and Mechanistic Insights into C-P Bond Hydrolysis by Phosphonoacetate Hydrolase” Chem. Biol. 2011, 18, 1230-1240. PMCID: PMC4321816

164. Wang, H.; van der Donk, W.A.* “Substrate selectivity of the S-glycosyltransferase from sublancin biosynthesis” J. Am. Chem. Soc. 2011, 133, 16394–16397. PMCID: PMC3191765 163. DeSieno, M.A.; van der Donk, W.A.; Zhao, H.* “Characterization and Application of the Fe(II) and

α-Ketoglutarate Dependent Hydroxylase FrbJ” Chem. Comm. 2011, 47, 10025-10027. PMCID: PMC4091617

162. Velásquez, J.E.; Zhang, X.; van der Donk, W.A.* “Biosynthesis of the Antimicrobial Peptide Epilancin 15X and its Unusual N-terminal Lactate Moiety” Chem. Biol. 2011, 18, 857-867. PMCID: PMC3161514

161. Ökesli, A.; Cooper, L.E.; Fogle, E.J.; van der Donk, W.A.* “Nine Posttranslational Modifications During the Biosynthesis of Cinnamycin” J. Am. Chem. Soc. 2011, 133, 13753–13760. PMCID: PMC3163434

160. Peck, S.C.; Cooke, H.A.; Cicchillo, R.M.; Nair, S.K.; van der Donk W.A.* “Mechanism and Substrate Recognition of Hydroxyethylphosphonate Dioxygenase” Biochemistry 2011, 50, 6598-6605. PMCID: PMC3143709

159. Borisova, S.A.; Christman, H.D.; Mourey-Metcalf, M.E.; Zulkepli, N.A.; Zhang, J.K.; van der Donk, W.A.; Metcalf, W.W.* “Genetic and biochemical characterization of a pathway for the degradation of 2-aminoethylphosphonate in Sinorhizobium meliloti 1021” J. Biol. Chem. 2011, 286, 22283-22290. PMCID: PMC3121374

158. Knerr, P.J.; Tzekou, A.; Ricklin, D.; Qu, H.; van der Donk, W.A.*; Lambris, J.D.* “Synthesis and Activity of Thioether-containing Analogues of the Complement Inhibitor Compstatin” ACS Chem. Biol. 2011, 6, 753-760. PMCID: PMC3137721

157. Gut, I.M.; Blanke, S.R. *; van der Donk, W.A.* “Mechanism of Nisin Inhibition of Bacillus anthracis Spore Outgrowth” ACS Chem. Biol. 2011, 6, 744-752. PMCID: PMC3178273

156. Circello, B.T.; Miller, C.G.; Lee, J.-H.; van der Donk,W.A.; Metcalf, W.W.* “The antibiotic dehydrophos is converted to a toxic pyruvate analog by peptide bond cleavage in Salmonella enterica” Antimicrob. Agents Chemother. 2011, 55, 3357-3362. PMCID: PMC3122408 155. Whitteck, J.T.; Malova, P.; Peck, S.C.; Cicchillo, R.M.; Hammerschmidt, F.*; van der Donk,

W.A.* “On the Stereochemistry of 2-Hydroxyethylphosphonate Dioxygenase” J. Am. Chem. Soc. 2011, 133, 4236-4239. PMCID: PMC3069692

154. Gut, I.M.; Tamilselvam, B.; Prouty, A.M.; Stojkovic, B.; Czeschin, S.; van der Donk, W.A.*; Blanke S.R.* “Bacillus anthracis spore interactions with mammalian cells: Relationship between germination state and the outcome of in vitro infections” BMC Microbiol. 2011, 11, 46. PMCID: PMC3060849

153. Goto, Y.; Ökesli, A.; van der Donk, W.A.* “Mechanistic studies of Ser/Thr dehydration catalyzed by a member of the LanL Lanthionine synthetase family” Biochemistry 2011, 50, 891-898. PMCID: PMC3031989

152. Oman, T.J.; Boetcher, J.D.; Wang, H.; Okalibe, X.N.; van der Donk, W.A.* “Sublancin is not a Lantibiotic but an S-linked Glycopeptide” Nat. Chem. Biol. 2011, 2, 78-80. PMCID: PMC3060661 151. Wu, G.; Lü, J.-M.; Kulmacz, R.J. van der Donk, W.A.; Tsai, A.L.* “Cyclooxygenase reaction mechanism of prostaglandin H synthase from deuterium kinetic isotope effects” J. Inorg. Biochem. 2011, 105, 382-390. PMCID: PMC3049311 150. Lü, J.-M.; Rogge, C.E.; Wu, G.; Kulmacz, R.J. van der Donk, W.A.; Tsai, A.L.* “Cyclooxygenase

reaction mechanism of PGHS — Evidence for a reversible transition between a pentadienyl radical and a new tyrosyl radical by nitric oxide trapping” J. Inorg. Biochem. 2011, 105, 356-365. PMCID: PMC3053578

Page 14: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

14

149. Tsai, A.L.*; Wu, G.; Rogge, C.E.; Lü, J.-M.; Peng, S.; van der Donk, W.A.; Palmer, G.; Gerfen, G.J.; Kulmacz, R.J. “Structural comparisons of arachidonic and acid-induced radicals formed by prostaglandin h synthase-1 and -2” J. Inorg. Biochem. 2011, 105, 366-374. PMCID: PMC3073652 148. Shi, Y.; Yang, X.; Garg, N.; van der Donk, W.A.* “Production of Lantipeptides in Escherichia coli”

J. Am. Chem. Soc., 2011, 133, 2338-2341. PMCID: PMC3044485 147. Velásquez, J.E.; and van der Donk, W.A.* “Genome Mining for Ribosomally Synthesized Natural Products” Curr. Opin. Chem. Biol. 2011, 15, 11-21. PMCID: PMC3090663 146. Nair, S.K. and van der Donk, W.A.* “Structure and Mechanism of Enzymes Involved in

Biosynthesis and Breakdown of the Phosphonates Fosfomycin, Dehydrophos, and Phosphinothricin” Arch. Biochem. Biophys. 2011, 505, 13-21. PMCID: PMC3040005

145. Bindman, N.; Merkx R.; Koehler, R.; Herrman, N.; van der Donk, W.A.* “Photochemical Cleavage of Leader Peptides” Chem. Comm. 2010, 46, 8935-8937. PMCID: PMC3100556 144. van der Donk, W.A.; Krebs, C.; Bollinger Jr., J.M. “Substrate Activation by Iron Superoxo Intermediates” Curr. Opin. Struct. Biol. 2010, 20, 673-683. PMCID: PMC3030196 143. Kuemin, M.; van der Donk, W.A.* “Structure-activity relationships of the phosphonate antibiotic dehydrophos” Chem. Comm. 2010, 46, 7694-7696. PMCID: PMC3109733 142. Lee, J.H; Bae, B.; Kuemin, M.; Circello, B.T. Metcalf, W.W.; Nair, S.K.; van der Donk W.A.* “Characterization and Structure of DhpI, a Phosphonate O-Methyltransferase Involved in Dehydrophos Biosynthesis” Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 17557-17562.

PMCID: PMC2955109 141. Clark, K.M.; Yu, Y.; Marshall, N.; Sieracki, N.; Nilges, M.; Blackburn, N.; van der Donk, W.A.*; Lu, Y.* “Transforming a Blue Copper into a Red Copper Protein: Engineering Cysteine and Homocysteine into the Axial Position of Azurin using Site-Directed Mutagenesis and Expressed Protein Ligation” J. Am. Chem. Soc. 2010 132, 10093-10101. PMCID: PMC2929572 140. Li, B.; Sher, D.; Kelly, L.; Shi, Y.; Huang, K.; Knerr, P.J.; Joewono, I.; Rusch, D.; Chisholm,

S.W.*; van der Donk. W.A.*, “Catalytic Promiscuity in the Biosynthesis of Cyclic Peptide Secondary Metabolites in Planktonic Marine Cyanobacteria” Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 10430-10435. PMCID: PMC2890784

139. Circello B.T.; Eliot A.C.; Lee, J.H.; van der Donk, W.A.; Metcalf, W.W.* “Molecular cloning and heterologous expression of the dehydrophos biosynthetic gene cluster” Chem. Biol. 2010, 17, 402-411. PMCID: PMC2888486

138. Goto, Y.; Li, B.; Claesen, J.; Shi, Y.; Bibb, M.J.; van der Donk, W.A.* “Discovery of Unique Lantibiotic Synthetases Reveals Mechanistic and Evolutionary Insights” PLoS Biol. 2010, 8, e1000339. PMCID: PMC2843593 137. Borisova, S.A.; Circello B.T.; van der Donk, W.A.*; Metcalf, W.W.* “Biosynthesis of

Rhizocticins, Antifungal Phosphonate Oligopeptides Produced by Bacillus subtilis ATCC6633” Chem. Biol. 2010,1, 28-37. PMCID: PMC2819989

136. Oman, T.; van der Donk, W.A.* “Follow the Leader: the Use of Leader Peptides to Guide Natural Product Biosynthesis” Nat. Chem. Biol.2010, 1, 9-18. PMCID: PMC3799897

135. Cooper, L.E.; Li, B.; van der Donk, W.A.* “Biosynthesis and Mode of Action of Lantibiotics” in Comprehensive Natural Products II: Chemistry and Biology, Eds. Mander, L.; Liu, H.-W., Elsevier: Oxford, 2010. Volume 5, pp. 217-256.

134. Whitteck, J.T.; Cicchillo, R.M.; van der Donk, W.A.* “Hydroperoxylation by Hydroxyethyl-phosphonate Dioxygenase” J. Am. Chem. Soc. 2009, 131, 16225. PMCID: PMC2773148

133. Wecksler, A.T.; Kenyon, V.; Garcia, N.K.; Deschamps, J.D.; van der Donk, W.A.; Holman, T.R.* “Kinetic and Structural Investigations of the Allosteric Site in Human Epithelial 15-Lipoxygenase-2” Biochemistry 2009, 36, 8721-8730. PMCID: PMC2746553

Page 15: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

15

132. Oman, T.; van der Donk, W.A.* “Insights into the Mode of Action of the Two-Component Lantibiotic Haloduracin” ACS Chem. Biol. 2009, 10, 865-74. PMCID: PMC2812937

131. Levengood, M.R.; Knerr, P.J.; Oman, T.J.; van der Donk, W.A.* “In Vitro Mutasynthesis of Lantibiotic Analogs Containing Nonproteinogenic Amino Acids” J. Am. Chem. Soc. 2009, 131, 12024-25. PMCID: PMC2732204

130. Lee, M.V.; Ihnken, L.A.F.; You, Y.O.; McClerren, A.L.; van der Donk, W.A.*; Kelleher, N.L.* “Distributive and Directional Behavior of Lantibiotic Synthetases Revealed by High-Resolution Tandem Mass Spectrometry” J. Am. Chem. Soc. 2009, 131, 12258-64. PMCID: PMC2735757

129. Clark, K.M.; van der Donk, W.A.*; Lu, Y.* “Expressed Protein Ligation for Metalloprotein Design and Engineering”Methods Enzymol. 2009, 462, 98-115. PMCID: PMC2780537

128. Zhang, X.; van der Donk, W.A.* “Using Expressed Protein Ligation to Probe the Substrate Specificity of Lantibiotic Synthetases” Methods Enzymol. 2009, 462, 117-134. PMCID: PMC2780537

127. Lee, J.; Evans, B.S.; Li, G.; Kelleher, N.L.*; van der Donk, W.A.* “In vitro Characterization of a Heterologously Expressed Non-Ribosomal Peptide Synthetase Involved in Phosphinothricin Tripeptide Biosynthesis” Biochemistry 2009, 48, 5054-5056. PMCID: PMC2709985

126. Wecksler, A.T.; Jacquot, C.; van der Donk, W.A.*; Holman, T.R.* “Mechanistic Investigations of Human Reticulocyte15- and Platelet 12-Lipoxygenases with Arachidonic Acid” Biochemistry 2009, 48, 6259-67. PMCID: PMC2935259

125. Cicchillo, R.M.; Zhang, H.; Blodgett, J.A.V.; Whitteck, J.T.; Li, G.; Nair, S.K.*; van der Donk, W.A.*; Metcalf, W.W.* “An Unusual Carbon-Carbon Bond Cleavage Reaction During Phosphinothricin Biosynthesis” Nature 2009, 459, 871-874. PMCID: PMC2874955

124. You, Y.O.; Levengood, M. R.; Furgerson Ihnken, L.A.; Knowlton, A.K., van der Donk, W.A.* “Lacticin 481 Synthetase as a General Ser/Thr Kinase” ACS Chem. Biol.2009, 4, 379-385. PMCID: PMC2709986

123. Li, B.; Cooper, L.E.; van der Donk, W.A.* “In vitro Studies of Lantibiotic Biosynthesis” Methods Enzymol. 2009, 458, 533-558.

122. Levengood, M.R.; Kerwood, C.C.; Chatterjee, C.; van der Donk, W.A.* “Investigation of the Substrate Specificity of Lacticin 481 Synthetase Using Nonproteinogenic Amino Acids” ChemBioChem 2009, 10, 911-919. PMCID: PMC2737179

121. Metcalf, W.W.; van der Donk, W. A. “Biosynthesis of Phosphonic and Phosphinic Acid Natural Products” Ann. Rev. Biochem. 2009, 78, 65-94. PMCID: PMC2729427

120. Furgerson, L.A.; van der Donk, W.A* “Lantibiotics, Biosynthesis and Mode of Action of” in Wiley Encyclopedia of Chemical Biology, Begley, T.P., Ed. John Wiley & Sons, Inc., 2009.

119. Barry, A.N.; Clark, K.M.; Otoikhian, A.; van der Donk, W.A.; Blackburn, N.* “Selenocysteine positional variants reveal contributions to copper binding from cysteine residues in domains 2 and 3 of human copper chaperone for superoxide dismutase” Biochemistry 2008, 47, 13074-13083. PMCID: PMC2645929

118. Jacquot, C.; McGinley, C.M.; Plata, E.; van der Donk, W.A.* “Synthesis of 11-Thialinoleic Acid and 14-Thialinoleic Acid, Inhibitors of Soybean and Human Lipoxygenases” Org. Biomol. Chem. 2008, 6, 4242-4252. PMCID: PMC2883171

117. Gut, I.M.; Prouty, A.M.; Ballard, J. D.; van der Donk, W.A.*; Blanke, S.R.* “Inhibition of Bacillus anthracis Spore Outgrowth by Nisin” Antimicrob. Agents Chemother. 2008, 52, 4281-8428. PMCID: PMC2592879

116. Cooper, L.E.; McClerren, A.L; Chary, A.; van der Donk, W.A.* “Structure-Activity Relationship Studies of the Two-Component Lantibiotic Haloduracin” Chem. Biol. 2008, 15, 1025-1045. PMCID: PMC2633096

Page 16: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

16

115. Jacquot, C.; Peng, S.; van der Donk, W.A.* “Kinetic Isotope Effects in the Oxidation of Arachidonic Acid by Soybean Lipoxygenase-1” Bioorg. Med. Chem. Lett. 2008, 18 5959-5962. PMCID: PMC2652760

114. Furgerson Ihnken, L.A.; Chatterjee, C.; van der Donk, W.A.* “In Vitro Reconstitution and Substrate Specificity of a Lantibiotic Protease”Biochemistry 2008, 47 7352-7363. PMCID: PMC2574596

113. Patton, G.C.; Paul, M.; Cooper, L.E.; Chatterjee, C.; van der Donk, W.A.* “The Importance of the Leader Sequence for Directing Lanthionine Formation in Lacticin 481” Biochemistry 2008, 47 7342-7351. PMCID: PMC2574844

112. Jacquot, C.; Wecksler, A.T.; McGinley, C.M.; Segraves, E.N.; Holman, T.R.*; van der Donk, W.A.* “Isotope Sensitive Branching and Kinetic Isotope Effects in the Reaction of Deuterated Arachidonic Acids with Human 12- and 15-Lipoxygenases” Biochemistry 2008, 47, 7295-7303. PMCID: PMC2574664

111. Shao, Z.; Blodgett, J.A.V.; Circello, B.T.; Eliot, A.C.; Woodyer, R.; Li, G.; van der Donk, W.A., Metcalf, W.W.; Zhao, H.* “Biosynthesis of 2-Hydroxyethylphosphonate, an Unexpected Intermediate Common to Multiple Phosphonate Biosynthetic Pathways” J. Biol. Chem. 2008, 283, 23161-23168. PMCID: PMC2516978

110. Levengood, M.R.; van der Donk, W.A.* “Use of Lantibiotic Synthetases for the Preparation of Bioactive Constrained Peptides” Bioorg. Med. Chem. Lett. 2008, 18, 3025-3028. PMCID: PMC2452991

109. Fogle, E.J.; van der Donk, W.A.* “Pre-Steady State Studies of Phosphite Dehydrogenase Demonstrate that Hydride Transfer is Fully Rate-Limiting” Biochemistry 2007, 46, 13101-13108. PMCID: PMC2517116

108. Whitteck, J.T.; Ni, W.; Griffin, B.M.; Eliot, A.C.; Thomas, P.M.; Kelleher, N.M.; Metcalf, B.W.; van der Donk, W.A.* “Reassignment of the Structure of the Antibiotic A53868 Reveals an Unusual Amino Dehydrophosphonic Acid” Angew. Chem. Intl. Ed. Engl. 2007, 46, 9089-9092.

107. van der Donk, W.A.*; Booker, S.J.* “Never Stop Questioning” Curr.Opin. Chem. Biol. 2007, 11, 527-528.

106. Levengood, M.R.; Patton, G.C.; van der Donk, W.A.* “The Leader Peptide is not Required for Post-translational Modification by Lacticin 481 Synthetase” J. Am. Chem. Soc. 2007, 129, 10314-10315. PMCID: PMC2492579

105. Zhang, X.; Ni, W.; van der Donk, W.A.* “On the Regioselectivity of Thioether Formation by Lacticin 481 Synthetase” Org. Lett. 2007, 9, 3343-3346. PMCID: PMC2517117

104. Willey, J.M.*; van der Donk, W.A.* “Lantibiotics: Peptides of Diverse Structure and Function” Ann. Rev. Microbiol. 2007, 61, 477-501.

103. Blodgett, J.A.V.; Thomas, P.M.; Li, G.; Velasquez, J.E.; van der Donk, W.A.; Kelleher, N.L.; Metcalf, W.W.* “Unusual transformations in the biosynthesis of the antibiotic phosphinothricin tripeptide” Nat. Chem. Biol. 2007, 3, 480-485. PMCID: PMC4313788

102. McGinley, C.M.; Jacquot, C.; van der Donk, W.A.* “Synthesis of 7-Thiaarachidonic Acid as a Mechanistic Probe of Prostaglandin H Synthase-2” Bioorg. Med. ChemLett.2007, 17, 4049-4052. PMCID: PMC2040112

101. Li, B.; van der Donk, W.A.* “Identification of Essential catalytic Residues of the Nisin Cyclase NisC” J. Biol. Chem. 2007, 282, 21169-21175.

100. Paul, M; Patton, G.C.; van der Donk, W.A.* “Mutants of the Zinc Ligands of Lacticin 481 Synthetase Retain Dehydration Activity but Have Impaired Cyclization Activity” Biochemistry 2007, 46, 6268-76. PMCID: PMC2517114

99. You, Y.O.; van der Donk, W.A.* “Mechanistic Investigations of the Dehydration Reaction of Lacticin 481 Synthetase Using Site-Directed Mutagenesis” Biochemistry 2007, 46, 5991-6000.

Page 17: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

17

PMCID: PMC2517115 98. Zhang, X.; van der Donk, W.A.* “On the Substrate Specificity of Dehydration by Lacticin 481

Synthetase” J. Am. Chem. Soc. 2007, 129, 2212-2213. PMCID: PMC2517113 97. Li, G.; van der Donk, W.A.* “Efficient Synthesis of Suitably Protected β-Difluoroalanine and

γ-Difluorothreonine from L-Ascorbic Acid” Org. Lett. 2007, 9, 41-44. PMCID: PMC2593874 96. Levengood, M.; van der Donk, W.A.* “Dehydroalanine-containing peptides: preparation from

phenylselenocysteine and utility in convergent ligation strategies” Nat. Protocols 2007, 1, 3001-3010.

95. Woodyer, R.; Li, G.; Zhao, H.;* van der Donk, W.A.* “New Insight into the Mechanism of Methyl Transfer During the Biosynthesis of Fosfomycin” Chem. Comm. 2007, 359-361.

94. Woodyer, R. D.; Shao, Z.; Metcalf, W. M.; van der Donk, W. A.;* Zhao, H.* “Heterologous Production of Fosfomycin and Identification of the Minimal Biosynthetic Gene Cluster” Chem. Biol. 2006, 13, 1171-1182.

93. van der Donk, W.A.* “Rings, Radicals, and Regeneration: the Early Years of a Bioorganic Laboratory” J. Org. Chem. 2006, 71, 9561-9571. PMCID: PMC2519235

92. Chatterjee, C.; Patton, G. C.; Cooper, L.; Paul, M.; Xie, L.; Ni, W.; van der Donk, W. A.* “Engineering Dehydro Amino Acids and Thioethers into Peptides Using Lacticin 481 Synthetase” Chem & Biol. 2006, 13, 1109-1117.

91. McClerren,A.L.; Cooper, L.E.; Quan, C.; Thomas, P.M.; Kelleher, N.L.; van der Donk, W.A.* “Discovery and in vitro Biosynthesis of Haloduracin, a New Two-component Lantibiotic” Proc. Natl. Acad. Sci. USA 2006, 103, 17243-17248.

90. Relyea, H.A.; van der Donk, W.A.* “Nature’s Way to Make the Lantibiotics” J. Chem. Educ., 2006, 83, 1769.

89. Liu, W.; Wang, L.H.; Pavol, F.; Hayashi, Y.; McGinley, C.M.; van der Donk, W.A.; Kulmacz, R.* “Arabidopsis thaliana Fatty Acid Alpha-dioxygenase-1: Evaluation of Substrates, Inhibitors, and Amino-Terminal Function” Plant Physiol. Biochem. 2006, 44, 284-293.

88. van der Donk, W.A. “Lighting Up the Nascent Cell Wall” ACS Chem Biol. 2006, 1, 425–428. 87. McGinley, C. M.; van der Donk, W. A.* “Synthesis of Site-Specifically Deuterated Arachidonic

Acid Derivatives Containing a Remote Tritium Radiolabel” J. Label. Cmpd. Radiopharm.2006, 49, 545-558.

86. Pesavento, R.P.; Pratt, D.A.; Jeffers, J.; van der Donk, W.A.* “Model Studies of the CuB Site of Cytochrome c Oxidase Utilizing a Zn(II) Complex Containing an Imidazole-Phenol Cross-Linked Ligand” Dalton Trans. 2006, 3326-3337.

85. Li, B.; Yu, J.-P. J.; Brunzelle, J. S.; Moll, G. N.; van der Donk, W. A.;* Nair, S. K.* “Structure and Mechanism of the Lantibiotic Cyclase Involved in Nisin Biosynthesis” Science, 2006, 311, 1464.

84. Miller, L. M.; Chatterjee, C.; van der Donk, W. A.; Kelleher, N. L.* “The Dehydratase Activity of Lacticin 481 Synthetase is Highly Processive” J. Am. Chem. Soc. 2006, 128, 1420-1421. PMCID: PMC2532561

83. McGinley, C.M.; Relyea, H.A.; van der Donk, W.A.* “Vitamin B12 Catalyzed Radical Cyclizations of Arylalkenes” Synlett, 2006, 211-214.

82. Pratt, D.A.; van der Donk, W.A.* “On the Role of Alkylcobalamins in the Vitamin B12-Catalyzed Reductive Dehalogenation of Perchloroethylene and Trichloroethylene” Chem. Commun.2006, 558-560.

81. Woodyer, R.; van der Donk, W.A. ;* Zhao, H. * “Optimizing a Biocatalyst for Improved NAD(P)H Regeneration: Directed Evolution of Phosphite Dehydrogenase” Comb. Chem. High Throughput Screen. 2006, 9, 237-245.

80. van der Donk, W.A. “The Protein Modification Repertoire” Nature Chem. Biol. 2005, 1, 243.

Page 18: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

18

79. Chatterjee, C.; Miller, L. M.; Leung, Y. L.; Xie, L.; Yi, M.; Kelleher, N.L.; van der Donk, W.A.* “Lacticin 481 Synthetase Phosphorylates its Substrate during Lantibiotic Production” J. Am. Chem. Soc. 2005, 127, 15332-15333.

78. Ide, N.D.; Galonić, D.P.; van der Donk, W.A.; Gin, D.Y.* “Conjugation of Selenols with Aziridine-2-Carboxylic Acid-Containing Peptides” Synlett 2005, 2011-2014.

77. Patton, G.C.; van der Donk, W.A.* “New Developments in Lantibiotic Biosynthesis and Mode of Action” Curr. Opin.Microbiol. 2005, 8, 543-551.

76. Zhang, X.; Ni, W.; van der Donk, W.A.* “Synthesis of Nonproteinogenic Amino Acids to Probe Lantibiotic Biosynthesis” J. Org. Chem. 2005, 70, 6685-6692. PMCID:PMC2525736

75. Woodyer, R.; Zhao, H.;* van der Donk, W.A.* “Mechanistic investigation of a highly active phosphite dehydrogenase mutant and its application for NADPH regeneration” FEBS J. 2005, 272, 3816-3827.

74. Pratt, D.A.; Pesavento, R.P.; van der Donk, W.A.* “Model Studies of the Histidine-Tyrosine Cross-Link in Cytochrome c Oxidase Reveal the Flexible Substituent Effect of the Imidazole Moiety” Org. Lett. 2005, 7, 2735-2738.

73. Galonić, D. P.; Ide, N. D.; van der Donk, W. A.;* Gin, D. Y. * “Aziridine-2-Carboxylic Acid-Containing Peptides: Application to Solution- and Solid-Phase Convergent Site-Selective Peptide Modification” J. Am. Chem. Soc. 2005, 127, 7359-69.

72. Relyea, H.A.; Wheatley, J. L.; Woodyer, R.; Rimkus, S.; van der Donk, W.A.* “Inhibition and pH Dependence of Phosphite Dehydrogenase” Biochemistry 2005, 44, 6640-6649.

71. Woodyer, R.; Wheatley, J. L.; Relyea, H.A.; Rimkus, S.; van der Donk, W.A.* “Site-Directed Mutagenesis of Active Site Residues of Phosphite Dehydrogenase” Biochemistry 2005, 44, 4765-4774.

70. Relyea, H.A.; van der Donk, W.A.* “Mechanism and Applications of Phosphite Dehydrogenase” Bioorg. Chem. 2005, 33, 171-89.

69. Woodyer, R.; Simurdiak, M.; van der Donk, W.A. ;* Zhao, H.* “Heterologous Expression, Purification, and Characterization of a Highly Active Xylose Reductase from Neurospora crassa” Appl. Environ. Microbiol.2005, 71, 1642-1647. PMC ID: PMC1065158

68. McCauley, K.M.; Pratt, D.A.; Wilson, S. R.; Shey, J.; Burkey, T.J.; van der Donk, W.A.* “Properties and Reactivity of Chlorovinylcobalamin and Vinylcobalamin and Their Implications for Vitamin B12-Catalyzed Reductive Dechlorination of Chlorinated Alkenes” J. Am. Chem. Soc. 2005, 127, 1126-1136.

67. Chatterjee, C. Paul, M.; Xie, L.; van der Donk, W.A.* “Biosynthesis and Mode of Action of Lantibiotics” Chem. Rev.2005, 105, 633-684.

66. Pratt, D. A.;* van der Donk, W.A.* “Theoretical Investigations into the Intermediacy of Chlorinated Vinyl Cobalamins in the Reductive Dehalogenation of Chlorinated Ethylenes” J. Am. Chem. Soc. 2005, 127, 384-396.

65. Galonić, D.; van der Donk, W.A.;* Gin, D.Y.* “Site-Selective Conjugation of Thiols with Aziridine-2-Carboxylic Acid-Containing Peptides” J. Am. Chem. Soc.2004, 126, 12712-12713.

64. Xie, L.; van der Donk, W.A.* “Post-Translational Modifications during Lantibiotic Biosynthesis” Curr. Opin. Chem. Biol.2004, 8, 498-507.

63. Paul, M.; van der Donk, W.A.* “Chemical and Enzymatic Synthesis of Lanthionines” Minirev. Org. Chem.2005, 1, 23-37.

62. Ralle, M.; Berry, S. M.; Gieselman, M.D.; Nilges, M.J.; van der Donk, W.A.; Lu, Y.; Blackburn, N. J.* “The Selenocysteine Substituted Blue Copper Center: Spectroscopic Investigations of Cys112SeCys Pseudomonas aeruginosa Azurin”J. Am. Chem. Soc. 2004, 126, 7244-7256.

61. Xie, L.; Miller, L.; Chatterjee, C.; Averin, O.; Kelleher, N.L.;* van der Donk, W.A.* “Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity” Science 2004, 303, 679-681.

Page 19: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

19

60. Peng, S.; McGinley, C.M.; .van der Donk, W.A.* “Synthesis of Site-Specifically Labeled Arachidonic Acids as Mechanistic Probes for Prostaglandin H Synthase” Org. Lett. 2004, 6, 349-352.

59. McGinley, C.M.; van der Donk, W.A.* “Enzymatic Hydrogen Atom Abstraction from Polyunsaturated Fatty Acids” Chem. Commun.2003, 2843-2846.

58. Okeley, N.M.; Paul, M.; Stasser, J.P.; Blackburn, N.J.;* van der Donk, W.A.* “SpaC and NisC, the Cyclases Involved in Subtilin and Nisin Biosynthesis, Are Zinc Proteins” Biochemistry 2003, 42, 13613-13624.

57. Galonić, D. P.; van der Donk, W.A.;* Gin, D.Y.* “Oligosaccharide-Peptide Ligation of Glycosyl Thiolates with Dehydropeptides: Synthesis of S-Linked Mucin-Related Glycopeptide Conjugates” Chem.–Eur. J. 2003, 24, 5997-6006.

56. Zhao, H.;* van der Donk, W.A.* “Regeneration of Cofactors for Use in Biocatalysis” Curr. Opin. Biotechnol. 2003, 14, 583-589.

55. Woodyer, R.; van der Donk, W. A.;* Zhao, H.* “Relaxing the Nicotinamide Cofactor Specificity of Phosphite Dehydrogenase by Rational Design” Biochemistry 2003, 42, 11604-11614.

54. Zhu, Y.; Gieselman, M. D.; Zhou, H.; Averin, O.; van der Donk, W.A.* “Biomimetic studies on the mechanism of stereoselective lanthionine formation” Org. Biomol. Chem. 2003, 1, 3304-3315.

53. Zhou, H.; Schmidt, D. M. Z.; Gerlt, J. A.;* van der Donk, W.A.* “Chemical and Enzymatic Synthesis of Fluorinated-Dehydroalanine-Containing Peptide” ChemBioChem, 2003, 4, 1206-1215.

52. van der Donk, W.A**; Zhao, H.* “Recent Developments in Pyridine Nucleotide Regeneration” Curr. Opin. Biotechnol. 2003, 14, 421-426.

51. Peng, S.; van der Donk, W.A.* “An Unusual Isotope Effect on Substrate Inhibition in the Oxidation of Arachidonic Acid by Lipoxygenase” J. Am. Chem. Soc. 2003, 125, 8988-8989.

50. Kulmacz, R.J**; van der Donk, W.A.; Tsai, A.-L. “Comparison of the Properties of Prostaglandin H Synthase-1 and -2” Progr. Lipid Res. 2003, 42, 377-404.

49. Blomberg, M. L.;* Blomberg, M.R.A.; Siegbahn, P. E. M.; van der Donk, W. A.; Tsai, A.-L. “A Quantum Chemical Study of the Synthesis of Prostaglandin G2 by the Cyclooxygenase Active Site in Prostaglandin Endoperoxide H Synthase 1” J. Phys. Chem. B, 2003, 107, 3297-3308.

48. McCauley, K.M.; Wilson, S.S.R.; van der Donk, W.A* “Characterization of Chlorovinylcobalamin, A Putative Intermediate in Reductive Degradation of Chlorinated Ethylenes” J. Am. Chem. Soc. 2003, 125, 4410-4411.

47. van der Donk, W.A.;* Tsai, A.-L.; Kulmacz, R.J. “The Cyclooxygenase Reaction Mechanism” Biochemistry 2002, 41, 15451-15458.

46. Hellwig, P.;* Pfitzner, U.; Behr, J.; Rost;, B. Pesavento, R.P.; van der Donk, W.A.; Gennis, R.B.; Michel, H.; Ludwig, B.; Mantele, W. “Vibrational modes of tyrosines in cytochrome c oxidase from Paracoccus denitrificans: FTIR and electrochemical studies on Tyr-D4-labeled and on Tyr280His and Tyr35Phe mutant enzymes” Biochemistry 2002, 41, 9116-9125.

45. McCauley, K.M.; Wilson, S.S.R.; van der Donk, W.A.* “Dichloroacetylene Is Not the Precursor to Dichlorinated Vinylcobaloxime and Vinylcobalamin in Cobalt Catalyzed Dechlorination of Perchloro- and Trichloroethylene” Inorg. Chem. 2002, 41, 5844-5848.

44. Nonnenberg, C.; van der Donk, W.A.;* Zipse, Z.* “Reductive Dechlorination of Trichloroethylene: A Computational Study” J. Phys. Chem. A 2002, 106, 8708-8715.

43. Peng, S.; Okeley, N.M.; Tsai, A.L.; Wu, G.; Kulmacz, R.J.; van der Donk, W.A.* “Synthesis of Isotopically Labeled Arachidonic Acids as Probes for the Reaction Mechanism of Prostaglandin H Synthase” J. Am. Chem. Soc. 2002, 124, 10785-10796.

Page 20: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

20

42. Xie, L.; Chatterjee, C.; Balsara, R.; Okeley, N.M.; van der Donk, W.A.* “Heterologous Expression and Purification of SpaB Involved in Subtilin Biosynthesis” Biochem.Biophys. Res. Commun. 2002, 295, 952-957.

41. Vrtis, J.M.; White, A.K.; Metcalf, W.W.; van der Donk, W.A.* “Phosphite Dehydrogenase: A Versatile Cofactor-Regeneration Enzyme” Angew.Chemie Intl. Ed. Engl. 2002, 41, 3257-3259.

40. Tsai, A. L.; Palmer, G.; Wu, G.; Peng, S.; Okeley, N. M.; van der Donk, W. A.; Kulmacz, R. J. “Structural Characterization of Arachidonyl Radicals Formed by Aspirin-treated Prostaglandin H Synthase-2” J. Biol. Chem. 2002, 277, 38311-38321.

39. Gieselman, M.; Zhu, Y.; Zhou, H.; Galonic, D.; van der Donk, W.A.* “Selenocysteine Derivatives for Chemoselective Ligations” ChemBioChem 2002, 3, 709-716.

38. Zhou, H.; van der Donk, W.A.* “Biomimetic Stereoselective Formation of Methyllanthionine” Org. Lett. 2002, 4, 1335-1338.

37. Berry, S.; Gieselman, M.D.; Nilges, M.J.; van der Donk, W.A.;* Lu, Y.* “An Engineered Azurin Variant Containing a Selenocysteine Copper Ligand” J. Am. Chem. Soc. 2002, 124, 2084-2085.

36. Shey, J.; McCauley, K.M.; Dearth, A.; Young, B.; van der Donk, W.A.* “Mechanistic Investigation of a Novel Vitamin B12-Catalyzed Carbon−Carbon Bond Forming Reaction, the Reductive Dimerization of Arylalkenes” J. Org. Chem. 2002, 67, 837-846.

35. McCauley, K.M.; Wilson, S.R.; van der Donk, W.A.* “Synthesis and Characterization of Chlorinated Alkenylcobaloximes to Probe the Mechanism of Vitamin B12-Catalyzed Dechlorination of Priority Pollutants” Inorg. Chem. 2002, 41, 393-404.

34. Xie, L.; van der Donk, W.A.* “Homemade cofactors: Self-processing in galactose oxidase” Proc. Natl. Acad. Sci. USA 2001, 98, 12863-12865. PMC ID: PMC60785

33. Pesavento, R.; van der Donk, W.A.* “Tyrosyl Radical Cofactors” Adv. Prot. Chem. 2001, 58, 317-385.

32. Gieselman, M.; Xie, L.; van der Donk, W.A.* “Synthesis of a Selenocysteine-Containing Peptide by Native Chemical Ligation” Org. Lett. 2001, 3, 1331-1334.

31. Zhu, Y.; van der Donk, W.A.* “Convergent Synthesis of Peptide Conjugates using Dehydroalanines for Chemoselective Ligations” Org. Lett. 2001, 3, 1189-1192.

30. Peng, S.; Okeley, N.M.; Tsai, A.-L.; Wu, G.; Kulmacz, R.; van der Donk, W.A.* “Structural Characterization of a Pentadienyl Radical Intermediate Formed during Catalysis by Prostaglandin H Synthase-2” J. Am. Chem. Soc. 2001, 123, 3609-3610.

29. Vrtis, J.M.; White, A.; Metcalf, W.W.; van der Donk, W.A.* “Phosphite Dehydrogenase: An unusual Phosphoryl Transfer Reaction” J. Am. Chem. Soc. 2001, 123, 2672-2673.

28. Zhou, H.; van der Donk, W.A.* “Synthesis of 2-Amino-3-fluoroacrylic Acid Containing Peptides” Org. Lett. 2001, 3, 593-596.

27. Shey, J.; van der Donk, W.A.* “Mechanistic Studies on Vitamin B12-Catalyzed Dechlorination of Chlorinated Alkenes” J. Am. Chem. Soc. 2000, 122, 12403-12404.

26. Okeley, N.M.; Zhu, Y.; van der Donk, W.A.* “Facile Chemoselective Synthesis of Dehydroalanine-Containing Peptides” Org. Lett. 2000, 2, 3603-3606.

25. Okeley, N.M.; van der Donk, W.A.* “Novel Cofactors via Post-translational Modifications of Enzyme Active Sites” Chem. Biol. 2000, 7, R159-R171.

24. McCauley, K.M.; Vrtis, J.M.; Dupont, J.; van der Donk, W.A.* “Insights into the Functional Role of the Tyrosine-Histidine Linkage in Cytochrome c Oxidase” J. Am. Chem. Soc. 2000, 122, 2403-2404.

Postdoctoral Research (Massachusetts Institute of Technology)

Page 21: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

21

23. van der Donk, W.A.; Yu, G.; Perez, L.; Sanchez, R.; Stubbe, J.; Samano, V.; Robins, M.J. “Detection of a New Substrate-Derived Radical during Inactivation of Ribonucleotide Reductase from Escherichia coli by Gemcitabine 5'-Diphosphate” Biochemistry 1998, 6419-6426.

22. van der Donk, W.A.; Gerfen, G.J.; Griffin, R.G.; Stubbe, J. “Direct EPR Spectroscopic Evidence for an Allylic Radical Generated from (E)-2'-Fluoromethylene-2'-deoxycytidine 5'-Diphosphate by E. coli Ribonucleotide Reductase” J. Am. Chem. Soc. 1998, 120, 4252-4253.

21. Stubbe, J.; van der Donk, W.A. “Protein Radicals in Catalysis” Chem. Rev. 1998, 98, 705-762. 20. Gerfen, G.J.; van der Donk, W.A.; Yu, G.; Farrar, C.; Griffin, R.G.; Stubbe, J.; McCarthy, J.R.;

Matthews, D.P.; Jarvi, E.T. “Characterization of a Substrate Derived Radical Detected During the Inactivation of Ribonucleotide Reductase from Escherichia coli by 2'-Fluoromethylene-2'-deoxycytidine 5'-Diphosphate” J. Am. Chem. Soc. 1998, 120, 3823-3835.

19. van der Donk, W.A.; Zeng, C.; Biemann, K.; Stubbe, J.; Hanlon, A.; Kyte, J. “Identification of an Active Site Residue of the R1 Subunit of Ribonucleotide Reductase from E. coli: Characterization of Substrate Induced Polypeptide Cleavage by C225SR1” Biochemistry 1996, 35, 10058-10067.

18. van der Donk, W.A.; Yu, G.; Silva, D.J.; Stubbe, J.; McCarthy, J.R.; Matthews, D.P.; Jarvi, E.T.; Resvick, R.J.; Wagner, E. “Inactivation of Ribonucleotide Reductase by (E)-2'-Fluoromethylene-2'-deoxycytidine 5'-diphosphate: A Paradigm for Nucleotide Mechanism Based Inhibitors” Biochemistry 1996, 35, 8381-8391.

17. McCarthy, J.; Sunkara, P.; Matthews, D.; Bitonti, A.; Jarvi, E.; Sabol, J.; Resvick, R.; Huber, E.; van der Donk, W.A.; Yu, G.; Stubbe, J. “Design of a Fluoro Olefin Cytidine Nucleoside as a Bioprecursor of a Mechanism-Based Inhibitor of Ribonucleotide Reductase” ACS Symp. Ser.1996, 639, 246-264.

16. van der Donk, W.A.; Stubbe, J.; Gerfen, G.J.; Bellew, B.F.; Griffin, R.G. “EPR Investigation of the Inactivation of E. coli Ribonucleotide Reductase with 2'-Azido-2'-deoxyuridine 5'-Diphosphate: Evidence for the Involvement of the Thiyl Radical of C225-R1” J. Am. Chem. Soc. 1995, 117, 8908-8916.

15. Stubbe, J.; van der Donk, W.A. “Ribonucleotide Reductases: Radical Enzymes with Suicidal Tendencies” Chem. Biol. 1995, 2, 783-801.

Graduate Research (Rice University/Texas A&M University) 14. Porte, A.; van der Donk, W.A. Burgess, K. “New and Efficient Synthesis of an Amino Acid for

Preparing Phosphine-Functionalized Peptidomimetics” J. Org. Chem. 1998, 63, 5262-5264. 13. Burgess, K.; van der Donk, W.A. “Asymmetric Hydroboration” in Advanced Asymmetric Synthesis,

Stephenson, G.R., Ed.; Chapman & Hall, London, 1996, 181-211. 12. Burgess, K.; van der Donk, W.A. “Tris(triphenylphosphine)rhodium(I) chloride” in Encyclopedia

of Reagents for Organic Synthesis, Paquette, L., Ed.; Wiley, New York, 1995, 1253-1261. 11. Burgess, K.; van der Donk, W.A. “Transition-metal Catalyzed Reactions of Boron Hydrides” in

Encyclopedia of Inorganic Chemistry; Vol. 3, King, R.B., Ed.; Wiley, New York, 1994, 1420. 10. Burgess, K.; van der Donk, W.A. “Titanium-Mediated Additions of Borohydride to Alkenes” J.

Am. Chem. Soc. 1994, 116, 6561-6569. 9. Burgess, K.; van der Donk, W.A. “The Importance of Phosphine-to-Rhodium Ratios in

Enantioselective Hydroborations” Inorg.Chim.Acta 1994, 220, 93-98. 8. Burgess, K.; van der Donk, W.A. “On Titanium-Promoted Hydroborations of Alkenes by

Borohydride and by Catecholborane”Organometallics 1994, 13, 3616-3620. 7. Burgess, K.; van der Donk, W.A. “On Hydroborations of Alkenes catalyzed by Titanium

Complexes”Tetrahedron Lett. 1993, 34, 6817-6820.

Page 22: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

22

6. Burgess, K.; van der Donk, W.A.; Westcott, S.A.; Marder, T.B.; Baker, R.T.; Calabrese, J.C. “Reactions of Catecholborane with Wilkinson's Catalyst: Implications for the Transition Metal-Catalyzed Hydroboration of Alkenes” J. Am. Chem. Soc. 1992, 114, 9350-9359.

5. Burgess, K.; van der Donk, W.A.; Jarstfer, M.B.; Ohlmeyer, M.J. “Further Evidence for the Role of d-p Bonding in Rhodium-Mediated Hydroborations” J. Am. Chem. Soc. 1991, 113, 6139-6144.

4. Burgess, K.; van der Donk, W.A.; Kook, A.M. “On Deuterium-Labeling Studies for Probing Rhodium-Catalyzed Hydroboration Reactions” J. Org. Chem. 1991, 56, 2949-2951.

3. Burgess, K.; van der Donk, W.A.; Ohlmeyer, M.J. “Enantioselectivehydroborations Catalyzed by Rhodium(+1)-complexes” Tetrahedron Asymmetry 1991, 2, 613-621.

Undergraduate Research (Leiden University, the Netherlands) 2. Haanstra, W.G.; van der Donk, W.A.J.W.; Driessen, W.L.; Reedijk, J.; Wood, J.S.; Drew, M.G.B.

“Unusual Behaviour of the Thioether Function of the Ligand 1,8-Bis(3,5-dimethyl-1-pyrazolyl)-3,6-dithiaoctane (bddo) towards Transition-metal Salts. X-ray Structures of a Green and a Red Modification of [Cu(bddo)Cl2]” J. Chem. Soc. Dalton Trans. 1990, 10, 3123-3128.

1. Haanstra, W.G.; van der Donk, W.A.J.W.; Driessen, W.L.; Reedijk, J.; Wood, J.S.; Drew, M.G.B. “Coordination Behaviour of the Ligand 1,9-Bis(3,5-dimethyl-1-pyrazolyl)-3,7-dithianonane (bddn) towards First Row Transition Metals. X-ray Structure of [Cu(bddn)(H2O)](BF4)2” Inorg.Chim.Acta 1990, 176, 299-305.

PATENTS (PROVISIONAL AND ISSUED) 1. Metcalf, W.W.; van der Donk, W.A.; Vrtis, J.M.; White, A.K.; Garcia-Costas, A.M. NAD

Phosphite oxidoreductase, a novel catalyst from bacteria for regeneration of NAD(P)H. U.S. Pat. Appl. 2004/0091985 A1, May 13, 2004; WIPO Pat. Appl. WO/2003/072726 A2, September 4, 2003; WIPO Pat. Appl. WO/2003/072726 A3, October 21, 2004; European Pat. Appl. EP1487974 A2, December 22, 2004; European Pat. Appl. EP1487974 A4, November 16, 2005; Canadian Pat. Appl. CA 2,480,639 A1, September 4, 2003.

2. Zhao, H.; Woodyer, R.; Simurdiak, M.; van der Donk, W.A. Highly Active Xylose Reductase from Neurospora crassa. U.S. Patent 7,592,163 B2, Sept. 22, 2009; U.S. Patent 7,381,553 B3, June 3, 2008; WIPO Pat. Appl. WO/2006/002021 A2, January 5, 2006; WIPO Pat. Appl. WO/2006/002021 A3, February 16, 2006.

3. van der Donk, W.A.; Xie, L; Chatterjee, C.; Paul, M. Compositions and Methods for Dehydration and Cyclization of Peptides, Synthetic Compounds, and Lantibiotics. U.S. Patent 7,785,825 B2, August 31, 2010.

4. Zhao, H.; Woodyer, R.D.; Metcalf, W.W.; van der Donk, W.A.; Johannes, T.W. Phosphite dehydrogenase Mutants for Nicotinamide Cofactor Regeneration. U.S. Patent 7,402,419 B2, July 22, 2008; WIPO Pat. Appl. WO/2004/108912 A2, December 16, 2004; WIPO Pat. Appl. WO/2004/108912 A3, April 7, 2005; European Pat. Appl. EP1636353 A2, December 16, 2004; Canadian Pat. Appl. CA 2,529,063 A1, December 16, 2004.

5. Zhao, H.; Woodyer, R.D.; Metcalf, W.W.; van der Donk, W.A.; Johannes, T.W. Engineered phosphite dehydrogenase mutants for nicotinamide cofactor regeneration. WIPO Pat. Appl. WO2006/074194 A2, July 13, 2006; WIPO Pat. Appl. WO2006/074194 A3, October 19, 2006.

6. van der Donk, W.A.; Cooper, L.E.; McClerren, A. L. Two component Bacillus lantibiotic and methods for producing and using the same. U.S. Patent 7,985,837 B2, July 26, 2011.

7. Metcalf, W.W.; van der Donk, W.A.; Zhang, J.; Circello, B.T.; Borisova, S.A. Compositions and methods for the synthesis of APPA-containing peptides. U.S. Patent 8,372,601 B2, Feb. 12, 2013.

Page 23: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

23

8. Lambris, J.D.; van der Donk, W.A. Modified Compstatin with improved stability and binding properties. U.S. Pat. Appl. US/2014/0113874 A1, April 24, 2014; WIPO Pat. Appl. WO/2012/040259 A2, March 29, 2012; WIPO Pat. Appl. WO/2012/040259 A3, March 29, 2012.

9. van der Donk, W.A.; Tang, W. Higher performance proteases for scarless tag removal. U.S. Pat. Appl. US/2017/0240878 A1, August 24, 2017; WIPO Pat. Appl. WO/2015/175576 A2, November 19, 2015; WIPO Pat. Appl. WO/2015/175576 A3, March 17, 2016.

10. van der Donk, W.A.; Garg, N.; Goto, Y.; Tang, W. Class I and II Lantibiotics from Geobacillus denitrificans. U.S. Patent 9,326,523 B2, May 3, 2016; WIPO Pat. Appl. WO/2013/119821 A1, August 15, 2013.

11. Metcalf, W.W. ; Ju, K.-S.; Gao, J.; Doroghazi, J.R.; van der Donk, W.A. Phosphonic acid compounds and screening method. U.S. Patent 9,993,490 B2, June 12, 2018; WIPO Pat. Appl. WO/2016/014539 A1, January 28, 2016.

12. van der Donk, W.A.; Okesli, A.; Yang, X.; Hetrick, K.; Walker, M. Biosynthesis and engineering of lanthipeptides. U.S. Pat. Appl. US/2017/0204400 A1, July 20, 2017; WIPO Pat. Appl. WO/2016/049656 A1, March 31, 2016.

PRESENTATIONS CHRONOLOGICAL Scheduled Presentations 2019-2020 276. Pacifichem 2020, December 15-20, 2020, Honolulu, Hawaii. 275. Biocatalysis Gordon Research Conference, Southern New Hampshire University, Manchester,

NH, July 12 - 17, 2020 274. 2020 Frontiers in Chemical Biology, Hong Kong University, February 17, 2020. 273. 2020 International Symposium on Chemical Biology, January 22 - 24, 2020, Geneva, Switzerland. “Natural Product Biosynthesis by Posttranslational Modification” 272. Schneller Frontiers lecture, Auburn University, November 14, 2019. 271. 2019 Cold Spring Harbor Asia Conference on Chemical Biology, Suzhou, China, October 28-

November 1, 2019. “Biosynthesis and Engineering of Macrocyclic Peptides” 270. Rowena Matthews Lecture, Department of Biological Chemistry, University of Michigan Medical

School, September 24, 2019. 269. Genetics of Industrial Microorganisms Congress (GIM2019), Pisa, Italy, September 8-12, 2019. “Posttranslational Modifications during Cyclic Peptide Biosynthesis” Presentations 2000-2019 268. 1st International RiPP Conference, Granada, Spain, April 24-26, 2019. “Biosynthesis and Engineering of Polycyclic Peptides” 267. 15th Annual Protein Engineering Summit (PEGS), Boston, MA, April 8-9, 2019. “Yeast Display of Post-Translationally Modified Polycyclic Peptides” 266. Invited speaker, American Society of Biochemistry and Molecular Biology (ASBMB) chapter at

Eastern Illinois University, Charleston, IL, April 3, 2019. “Why Do We Not Have New Antibiotics?” 265. Sanders Tri-Institutional Chemical Biology Seminar Series, Rockefeller and Memorial Sloan

Kettering Cancer Center, March 22, 2019. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 264. Biology Colloquium Series, MIT, February 12, 2019. “Biosynthesis, Engineering and Applications of Macrocyclic Peptides” 263. 26th Enzyme Mechanisms Conference, New Orleans, January 9, 2019.

Page 24: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

24

“Posttranslational Modifications during Cyclic Peptide Biosynthesis” 262. David Hopwood lecture, John Innes Centre, Norwich, UK, November 27, 2018. “Posttranslational Modifications during Cyclic Peptide Biosynthesis” 261. H.H. King lecture, Kansas State University, November 9, 2018. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 260. John Daly lecture, National Institutes of Health, October 26, 2018. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 259. Dept. of Clinical Microbiology, NIH, October 25, 2018. “Discovery of New Antimicrobial Phosphonates Using Genomics” 258. EMBO Symposium “Enzymes, biocatalysis and chemical biology: the new frontiers” Pavia, Italy,

September 9-12, 2018. “Biosynthesis and engineering of cyclic peptide antibiotics” 257. European Peptide Symposium, Dublin, Ireland. August 26-September 1, 2018. “Posttranslational Modifications during Cyclic Peptide Biosynthesis” 256. Myron and Muriel Bender lectures, Northwestern University, August 6-7, 2018. “Leader Peptide Guided Natural Product Biosynthesis” “Phosphonate Biosynthesis: A Treasure Trove for Novel Enzymology” 255. Bioorganic Chemistry Gordon Conference, Andover, New Hampshire, June 10-15, 2018. “Leader Peptide Guided Natural Product Biosynthesis” 254. 6th International Symposium on Antimicrobial Peptides (AMP2018), Poitiers, France, June 6,

2018. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 253. Symposium honoring Judith Klinman, University of Pennsylvania, May 9, 2018. “Leader Peptide Guided Natural Product Biosynthesis” 252. University of Minnesota, Department of Chemistry, February 22, 2018. “Phosphonate Biosynthesis: A Treasure Trove for Novel Enzymology” 251. Natural Product Discovery and Development in the Genomic Era, Society for Industrial

Microbiology and Biotechnology, Clearwater Florida, January 23, 2018. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 250. Mona Symposium on Natural Products & Medicinal Chemistry, University of the West Indies,

Jamaica, January 8-11, 2018. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 249. MilliporeSigma/Karcher Lecture, University of Oklahoma, December 8, 2017. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 248. Princeton University, November 29, 2017. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 247. University of Tokyo, November 12-19, 2017. “Personal reflections on moving from inorganic chemistry, to organic chemistry, to biosynthesis” “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 246. Backer lecture, University of Groningen, The Netherlands, October 30, 2017. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 245. University of Eindhoven, The Netherlands, October 27, 2017. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 244. Chemical Biology Lecture Series, Leiden University, the Netherlands. October 26, 2017. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 243. Alfred Hoffmann award lecture, University of Zürich, Switzerland, October 24, 2017. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 242. Department of Chemistry, ETH, Zürich, Switzerland, October 23, 2017. “Phosphonate Biosynthesis: A Treasure Trove for Novel Enzymology”

Page 25: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

25

241. 2017 Boulder Peptide Symposium, Boulder, CO, September 25-29, 2017. “Combinatorial Methods Towards Genetically Encoded Cyclic Peptides” 240. Alfred Benzon Symposium, Copenhagen University, Copenhagen, Denmark, August 21-24, 2017. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 239. Repligen Award lecture, ACS National meeting, Washington DC, August 20, 2017. “Two radical proteins: Hydroxyethylphosphonate dioxygenase and methylphosphonate synthase” 238. 2017 Society for Industrial Microbiology and Biotechnology Annual Meeting, Denver, CO, July

30-August 3, 2017. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 237. 2017 Gordon Research Conference (GRC) on Enzyme and Metabolic Pathways, Waterville

Valley, NH, July 16-21, 2017. “How Can One Enzyme Act on 30 Different Substrates?” 236. 2017 Gordon Research Seminar (GRS) on Enzymes, Coenzymes and Metabolic Pathways,

Waterville Valley, NH, July 16, 2017. “Phosphonate Biosynthesis: A Treasure Trove for Novel Enzymology” 235. 2017 American Peptide Symposium, Whistler, British Columbia, June 16-21, 2017. “Combinatorial Lanthipeptide Biosynthesis” 234. 9th US-Japan Seminar on the Biosynthesis of Natural Products, Lake Arrowhead, CA, May 30-

June 4, 2017. “Biosynthesis of Cyclic Peptide Antibiotics” 233. Novartis Chemical Sciences Lectureship, University of Wisconsin-Madison, May 4, 2017. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 232. Directing Biosynthesis V, Coventry, UK, March 22-24, 2017. “Directing RiPP Biosynthesis” 231. Washington University, St. Louis, MO, February 23, 2017. “Biosynthesis of Cyclic Peptide Antibiotics” 230. Grinnell College, February 10, 2017. “The looming antibiotics crisis: what can we do about it?” 229. Johns Hopkins University, Department of Chemistry, January 25, 2017. “Biosynthesis of Cyclic Peptide Antibiotics” 228. Northwestern University, January 6, 2017. “Biosynthesis of Cyclic Peptide Antibiotics” 227. Student Sponsored Nozaki Memorial Lecture Series, Dept. of Biochemistry, Duke University,

December 2, 2016. “Biosynthesis and Engineering of Cyclic Peptide Antibiotics” 226. Colloquium Series, University of Toronto, November 11, 2016. “Biosynthesis of Cyclic Peptide Antibiotics” 225. Medicinal Chemistry and Pharmacognosy Seminar Series, University of Illinois at Chicago,

November 4, 2016. “Biosynthesis of Cyclic Peptide Antibiotics” 224. Pfizer Award Symposium, ACS National Meeting, Philadelphia, August, 21-25, 2016. “RiPP biosynthesis: D-amino acids in ribosomally produced peptides” 223. Monsanto, St Louis, March 21, 2016. “Production of cyclic peptide libraries in heterologous hosts” 222. 4th Frontier Chemistry Center International Symposium, Hokkaido University, Sapporo, Japan,

February 23-24, 2016. “Phosphonate Biosynthesis: A Treasure Trove for Novel Chemistry” “Biosynthesis of Cyclic Peptide Antibiotics”

Page 26: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

26

221. Metals in Biology, GRC, January 24-28, 2016. “A Tale of Two Proteins: Hydroxyethylphosphonate Dioxygenase and Methylphosphonate

Synthase” 220. Synthetic Biology Symposium, Salk Institute, La Jolla, January 20-22, 2016. “Production of cyclic peptide libraries in heterologous hosts” 219. University of Alberta, Edmonton, Canada, January 11, 2016. “Biosynthesis of Cyclic Peptide Antibiotics” 218. Pacifichem, Symposium: “Biosynthesis of Natural Products,” December 15-19, 2015. “How does one enzyme make and break 32 chemical bonds?” 217. Pacifichem, Symposium: “Enzymes Essential to Biosphere Health: Bioremediation and

biogeochemical cycling,” December 15-19, 2015. “Formation and breakdown of compounds with phosphorus-carbon bonds” 216. Plenary Lecture, International Conference on Circular Proteins, November 1-4, 2015. Brisbane,

Australia. “Biosynthesis of lanthionine-containing peptides”

215. UC Berkeley/UCSF, SQB/Andrew Braisted Lecture, Oct 4, 2015 “Unexpected Posttranslational Modifications during Cyclic Peptide Biosynthesis” 214. Undergraduate Biochemistry Seminar, Marquette University, October 12, 2015. “Why do we not have new antibiotics, and what can we do about it?” 213. Boston College, Dept of Chemistry, Sept 8, 2015. “Biosynthesis of Cyclic Peptide Antibiotics”. Novartis lecture. 212. Eli Lilly, Indianapolis, August 25, 2015. 211. Keynote lecture, Vanderbilt Institute for Chemical Biology Student Research Symposium, August

13, 2015. “Evolution of peptide dehydratases involved in natural product biosynthesis” 210. American Society of Pharmacognosy, July 25-29, 2015. “Biosynthesis of Cyclic Peptide Antibiotics” 209. 16th International Conference on Advancing the Chemical Sciences (ISACS 16), June 15-18,

Zürich, Switzerland. “Biosynthesis of Cyclic Peptide Antibiotics” 208. Durham University, UK, June 1, 2015. “Biosynthesis of Cyclic Peptide Antibiotics” 207. University of Warwick, UK, May 27, 2015. “Biosynthesis of Cyclic Peptide Antibiotics” 206. Oxford University, Department of Chemistry, May 28, 2015. “Biosynthesis of Cyclic Peptide Antibiotics” 205. The Royal Society of Chemistry, London, May 26, 2015. “Biosynthesis of Cyclic Peptide Antibiotics” 204. Frontier's in Chemical Research Lectures, Texas A&M, April 6-8, 2015. “Phosphonate Biosynthesis: A Treasure Trove for Novel Chemistry” “Genome Mining for Novel Natural Products” “Biosynthesis of Cyclic Peptide Antibiotics” 203. American Society for Biochemistry and Molecular Biology annual meeting, March 28-April 1,

2015, Boston, MA. 202. Yale University, Department of Chemistry, March 3, 2015. “Posttranslational Modifications in Natural Product Biosynthesis” 201. Harvard University, Department of Chemistry, March 2, 2015. “Biosynthesis of Cyclic Peptide Antibiotics”

Page 27: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

27

200. DuPont Central Station, Wilmington, Delaware, February 13, 2015. “Biosynthesis and engineering of cyclic peptide natural products” 199. University of Texas Southwestern Medical School, January 29, 2015.

“Genome-Assisted Investigations of Natural Product Biosynthesis” 198. Natural Product Discovery and Development in the Post-Genomic Era Conference, Society for

Industrial Microbiology, January 11-15, 2015. “Posttranslational Modifications in Natural Product Biosynthesis”

197. University of Utah, Department of Chemistry, December 11, 2014. “Biosynthesis of Cyclic Peptide Antibiotics” 196. TSRI, Scripps Florida, November 6, 2014. “Biosynthesis of Cyclic Peptide Antibiotics” 195. University of Alberta, Department of Chemistry, September 29, 2014. “Biosynthesis of Cyclic Peptide Antibiotics” CANCELLED 194. 22nd IUPAC International Conference on Physical Organic Chemistry, Ottawa, Canada, August

10-15, 2014. “Use of tRNA in Natural Product Biosynthesis” 193. 2014 annual meeting Society for Industrial Microbiology and Biotechnology, St Louis, July 20-24 “Use of tRNA in Natural Product Biosynthesis” 192. Gordon Conference on Stereochemistry, Newport, RI, July 27-August 1, 2014. “Understanding Phosphonate Biosynthesis Through Investigations of Stereochemistry” 191. Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic, June 4, 2014. “Biosynthesis of Cyclic Peptide Antibiotics” 190. 36th Steenbock Symposium- Enzyme Structure and Function, University of Wisconsin-Madison,

May 22-24, 2014. “Applying Mo Cleland’s Ideas to Phosphite Dehydrogenase” 189. 2014 HHMI Science Meeting, Janelia Farms Research Center, May 6-8, 2014. “Non-Translational Functions of Aminoacyl tRNA in Natural Product Biosynthesis” 188. Institute for Cellular and Molecular Biology Seminar, University of Texas-Austin, April 24, 2014. “Posttranslational Modifications in Natural Product Biosynthesis” 187. Harvard University, Chemical Biology Retreat, April 18-19, 2014. “Combinatorial Biosynthesis of Cyclic Peptides” 186. Advances in Macrocyclic Peptide Synthesis and Applications Symposium, ACS National

Meeting, March 19, 2014. “Preparation of cyclic peptides by posttranslational modifications” 185. Marine Natural Products GRC, Ventura, CA, March 2-7, 2014.

“Lanthipeptide Biosynthesis in Marine Cyanobacteria” 184. JoAnne Stubbe Symposium, University of Pennsylvania, February 18, 2014. “Posttranslational Modifications in Natural Product Biosynthesis” 183. University of North Carolina-Chapel Hill, February 12, 2014.

“Biosynthesis of Cyclic Peptide Antibiotics” 182. North Carolina State University, February 11, 2014.

“Posttranslational Modifications in Natural Product Biosynthesis” 181. Keynote Lecture, NIH Chemical Biology Training Grant Symposium, University of Kansas,

January 24, 2014. “Posttranslational Modifications in Natural Product Biosynthesis” 180. Amgen, Westlake Village, CA, November 20, 2013. “Cyclic peptide biosynthesis by

posttranslational modifications” 179. Genentech Lecture 2013, Scripps Research Institute, La Jolla, CA, November 18, 2013. “Genome-

Assisted Investigations of Natural Product Biosynthesis” 178. 23rd Solvay Conference on Chemistry, Brussels, Belgium, October 16-19, 2013. “Natural Product Biosynthesis in the Genomic Age”

Page 28: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

28

177. 2013 SIMB (Society for Industrial Microbiology and Biotechnology) Annual Meeting, San Diego, August 11-15, 2013. “RiPPs: Ribosomally Synthesized and Posttranslationally Modified Peptide Natural Products”

176. 27th Annual Symposium of the Protein Society, Boston, July 22, 2013. “RiPPs: Ribosomally Synthesized and Posttranslationally Modified Peptide Natural Products”

175. American Peptide Society Symposium, Kona, Hawaii, June 23, 2013. “RiPPs: Ribosomally Synthesized and Posttranslationally Modified Peptide Natural Products”

174. Laptop (Lantibiotic production: technology, optimization and improved process) Workshop, Verona, Italy, June 16-17, 2013. “In vitro studies of lantibiotic biosynthetic enzymes”

173. Novartis, San Francisco, May 8, 2013. “Genome-Assisted Investigations of Natural Product Biosynthesis” 172. David Gin Memorial Symposium, Memorial Sloan Kettering Cancer Center, April 30, 2013. “Genome-Assisted Investigations of Natural Product Biosynthesis” 171. MIT, Department of Chemistry, April 29, 2013. “Phosphonate Biosynthesis: A Treasure Trove for Novel Chemistry” 170. ACS Chem. Biol. Lecture, ACS National Meeting, New Orleans, April 9, 2013. “Stereochemistry and Mode of Action of Lantibiotics” 169. Society for General Microbiology, Manchester, UK, March 25-28, 2013.

“Posttranslational Modifications in Natural Product Biosynthesis” 168. UIUC, Department of Bioengineering, February 28, 2013. “RiPPs: a Treasure Trove for Bioengineering” 167. Kharasch lectures, University of Chicago, January 25-30, 2013. Lecture 1 “Phosphonate Biosynthesis: A Treasure Trove for Novel Chemistry” Lecture 2 “Posttranslational Modifications in Natural Product Biosynthesis” Lecture 3 “Genome Mining for New Natural Products” 166. 23rd Enzyme Mechanisms Conference, Coronado, CA. January 7, 2013. “Evolution of Lanthipeptide Synthetases” 165. Annual Symposium on Recent Advances in Synthesis and Chemical Biology XI, Centre for Synthesis and Chemical Biology, Dublin, Ireland. December 14, 2012. “Posttranslational modifications in natural product biosynthesis” 164. T.T. Tchen Memorial Lecture, Wayne State University, September 28, 2012. “Posttranslational modifications in natural product biosynthesis” 163. University of Nebraska, Dept of Chemistry, August 24, 2012. “Posttranslational modifications in natural product biosynthesis” 162. Colorado State University, Dept of Chemistry, August 23, 2012. “Posttranslational modifications in natural product biosynthesis” 161. Natural Products GRC, July 22-26, 2012. “Combining synthetic and biosynthetic chemistry to prepare natural product analogs” 160. Dowd lecturer, University of Pittsburgh, May 2012. Lecture 1: “Posttranslational modifications in natural product biosynthesis” Lecture 2: “Phosphonate Natural Products: Discovery and Biosynthesis” 159. Purdue University, Dept. of Biochemistry, April 3, 2012. “Posttranslational modifications in Natural Product Biosynthesis” 158. ACS National Meeting, San Diego 2012. “Chemical and Enzymatic Synthesis of S-linked Glycopeptides” 157. ACS National Meeting, San Diego 2012. “Discovery and Biosynthesis of Phosphonate Natural Products”

Page 29: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

29

156. Texas A&M University, Dept. of Chemistry, February 29, 2012. “Posttranslational Modifications in Natural Product Biosynthesis” 155. HHMI meeting on Microbes and Immunology, February 14-17, 2012. “Posttranslational Modifications in Secondary Metabolism” 154. 16th International Symposium on the Biology of Actinomycetes (ISBA16), Puerto Vallarta, Mexico, December 11-15, 2011. “Biosynthesis of Lantipeptides in Actinomycetes” 153. Center for Integrated Protein Science Fest, Munich, September 14-17, 2011. “Posttranslational modifications in natural product biosynthesis” 152. International Conference on the Chemistry of Antibiotics (ICCA-12), Berlin, September 9-13, 2011. “Posttranslational modifications in natural product biosynthesis” 151. Chemistry Symposium, Boston University, June 24, 2011. “Post-translational modifications in natural product biosynthesis” 150. UC Berkeley, May 2, 2011. “Posttranslational modifications in natural product biosynthesis” 149. Princeton, April 20, 2011. “Post-translational modifications in natural product biosynthesis: lantibiotics and S-linked glycopeptides” 148. University of East Anglia, Norwich, UK, March 9, 2011. “Phosphonate Natural Products: Discovery and Biosynthesis” 147. University of Bristol, UK, March 7, 2011 “Phosphonate Natural Products: Discovery and Biosynthesis” 146. Case Western Reserve University, February 24, 2011. “Post-translational modifications in natural product biosynthesis” 145. “Rockefeller University, January 12, 2011. Post-translational modifications in cyclic peptide biosynthesis” 144. Pacifichem 2010, Honolulu, December 15-20. “Post-translational modifications during lantibiotic biosynthesis” 143. University of Wisconsin, Department of Chemistry, December 7, 2010. “Post-translational modifications in natural product biosynthesis” 142. Utrecht University, October 12, 2010. “Post-translational modifications in natural product biosynthesis” 141. Universitaet des Saarlandes, October 7, 2010. “Post-translational modifications in natural product biosynthesis” 140. International Symposium of the DFG Research, Post-Genomic Strategies for New Antibiotic Drugs and Targets Königswinter (Germany), October 4-6, 2010. “Leader Peptide Directed Biosynthesis: Lantibiotics Engineering” 139. Directing Biosynthesis II: Discovery; Evolution; Function conference Durham, UK September 13-17, 2010. “Leader Peptide Directed Biosynthesis: Lantibiotics Engineering” 138. 240th National ACS meeting, August 23, 2010, Boston. “Post-translational modifications in natural product biosynthesis” 137. 240th National ACS meeting, August 24, 2010, Boston. “Unusual Enzymatic Transformations during Phosphonate Biosynthesis” Symposium in honor of Perry Frey receiving Gordon Hammes award. 136. NAICONS/Ktedogen, Milano, Italy, June 17, 2010. “Post-translational modifications in natural product biosynthesis”

Page 30: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

30

135. Trends in Enzymology Conference, Locarno, Switzerland, June 13-17, 2010. “Leader Peptide Directed Biosynthesis: Lantibiotics Engineering “ 134. Bürgenstock Conference, Brunnen, Switzerland, May 2-7, 2010. “Genome-Assisted Investigations of Natural Product Biosynthesis” 133. University of Texas Southwestern Medical Center, Dept. of Biochemistry, May 20, 2010. “Post-translational modifications in natural product biosynthesis” 132. Georgia Tech, Department of Chemistry, April 29, 2010. “Post-translational modifications in natural product biosynthesis” 131. Howard Hughes Medical Institute, Chevy Chase, MD, April 18-21, 2010. Conference on Infection, Inflammation and Immunity “New Methods for the Discovery of Anti-infectives” 130. 239th National ACS meeting, March 2010, San Francisco. “New methods for the discovery and synthesis of natural products” 129. UCLA, Department of Chemistry, February 26, 2010. “Post-translational modifications in natural product biosynthesis” 128. Caltech, Department of Chemistry, February 24, 2010. “Post-translational modifications in natural product biosynthesis” 127. Shanghai Institute of Organic Chemistry, December 23, 2009. “New methods for the discovery and synthesis of natural products” 126. Albert Einstein College of Medicine, December 8, 2009. “Post-translational modifications in natural product biosynthesis” 125. The Pennsylvania State University, Department of Chemistry, November 12, 2009. “New Methods for the Discovery and Synthesis of Antibiotics” 124. Leiden University, the Netherlands, Department of Chemistry, October 30, 2009. “Unusual Reactions Catalyzed by Non-heme Iron Proteins” 123. Albion College, Department of Chemistry, October 29, 2009. “New methods for the Discovery and Synthesis of Natural Products “ 122. Michigan State University, Department of Chemistry, East Lansing, MI, October 28, 2009. “New methods for the Discovery and Synthesis of Natural Products “ 121. Howard Hughes Medical Institute, Chevy Chase, MD. April 18-21, 2010. Conference on Proteins: Structure, Function, Evolution “Lords of the Rings: Lantibiotic Synthetases” 120. Cornell University, Department of Chemistry and Chemical Biology, September 14, 2009. “New Methods for the Discovery and Synthesis of Antibiotics” 119. Chemical Biology Symposium, State University of New York, Buffalo, September 11, 2009. “New methods for the discovery and synthesis of antibiotics” 118. OBC lecture. Royal Society of Chemistry/IUPAC Congress, Glasgow, Scotland, August 3-7,

2009. “Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics” 117. Enzymes, Coenzymes and Metabolic Pathways GRC, Waterville Valley, NH, July 5-10, 2009. “Unusual Transformations during the Biosynthesis of Phosphonate Natural Products” 116. Conference on Pathways, Networks, and Systems, Corfu, Greece, June 6-9, 2009. “Mining microbial genomes for novel antibiotics” 115. Memorial Sloan Kettering Cancer Center, May 12, 2009. “New methods for the discovery and synthesis of antibiotics” 114. Queen’s University, Dept. of Chemistry, Kingston, Ontario Canada, May 1, 2009. “Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics” 113. NIH Summit on Natural Products and Biomedical Science, April 28-29, 2009

Page 31: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

31

“Genome Mining for Novel Lantibiotics” 112. University of South Florida, Dept. of Chemistry, Tampa, April 2, 2009. “Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics” 111. University of Maryland, Dept. of Chemistry, March 10, 2009.

“Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics” 110. Wesleyan University, Dept. of Chemistry, Middletown, CT, February 27, 2009.

“Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics” 109. Tufts University, Dept. of Chemistry, Medford, MA, January 27, 2009. “Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics” 108. University of Rochester, Department of Chemistry, Rochester, NY, December 5, 2008.

“Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics” 107. University of Kentucky, Department of Pharmaceutical Sciences, College of Pharmacy,

Lexington, KY, November 21, 2008. “Biosynthesis of lantibiotics, complex macrocyclic thioethers”

106. ETH, Dept of Chemistry, October 13, 2008. “Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics”

105. Tour “3ème Cycle” of Swiss Universities: Universities of Geneva, Lausanne, Berne, Basel, Fribourg and Neuchâtel, Switzerland, October 6-13, 2008. “Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics” and “Discovery, Structure, and Biosynthesis of Phosphonate Natural Products”

104. University of Georgia, Department of Chemistry, September 11, 2008. “Biosynthesis of Lantibiotics, Complex Macrocylic Thioethers”

103. MIT, Dept of Chemistry, July 12, 2008. Symposium in honor of JoAnne Stubbe. “Biosynthesis of lantibiotics, complex macrocyclic antibiotics”

102. 7th US-Japan Seminar on Biosynthesis of Natural Products, San Diego, June 22- June 26, 2008 “Biosynthesis of lantibiotics, complex macrocylic thioethers” 101. Novartis Lecture, University of Michigan, Department of Chemistry, May 19, 2008.

“Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics” 100. Massachusetts General Hospital Department of Molecular Biology/Harvard Medical School

Department of Genetics, May 7, 2008. “Biosynthesis of Lantibiotics, Polycyclic Thioether Antibiotics”

99. Johns Hopkins University School of Medicine, Department of Pharmacology, Baltimore, MD, April 23, 2008. “Biosynthesis of lantibiotics, complex macrocyclic thioethers”

98. Illinois Wesleyan University, Department of Chemistry, April 4, 2008. “Lacticin 481 Synthetase, the Lord of the Rings” 97. Plenary Lecture, Annual meeting of the German Society for General and Applied Microbiology

and the German Society for Biochemistry and Molecular Biology, Frankfurt, Germany, March 9-12, 2008. “Biosynthesis of lantibiotics, complex macrocylic thioethers”

96. University of Minnesota – Twin Cities, Department of Biochemistry, Molecular Biology & Biophysics, Minneapolis, MN, February 6, 2008. “Biosynthesis of lantibiotics, complex macrocyclic thioethers”

95. University of British Columbia, Department of Chemistry and Simon Fraser University, Departments of Chemistry, Vancouver, BC, Canada, January 8 and 9, 2008. “Biosynthesis of lantibiotics, complex macrocyclic thioethers”

94. John Innes Centre, Norwich Bioscience Institutes, Norwich, UK, October 5, 2007. “Biosynthesis of lantibiotics, complex macrocylic thioethers”

Page 32: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

32

93. Columbia University, Department of Biological Sciences, September 24, 2007. “Post-translational modifications in lantibiotic biosynthesis”

92. American Chemical Society, 234th National Meeting, Boston, MA, August 19-23, 2007 “Biosynthesis of lantibiotics, complex macrocylic thioethers” 91. Society for Industrial Microbiology, Annual Meeting, Denver, CO, July 29-August 2, 2007 “Biosynthesis of the Lantibiotics Haloduracin and Nisin” 90. Tetrahedron 50th Anniversary Symposium, June 27-29, 2007, Berlin, Germany. “Biosynthesis of lantibiotics, complex macrocylicthioethers” 89. The Ohio State University, CBIP Program Symposium, May 8, 2007. “Biosynthesis of lantibiotics, complex macrocyclicthioethers” 88. Yale University, Dept. of Chemistry, April 18, 2007. “Biosynthesis of lantibiotics, complex macrocyclicthioethers” 87. American Chemical Society National Meeting, Chicago, IL, March 26, 2007.

2007 Nakanishi Prize Symposium invited lecture: “Posttranslationally modified antimicrobial peptides”

86. University of California, San Francisco, Dept. of Pharmaceutical Chemistry, March 15, 2007. “Chemistry and Biology of Lanthionine Biosynthesis” 85. Massachusetts Institute of Technology, Department of Chemistry, February 13, 2007. “Chemistry and Biology of Lanthionine Biosynthesis” 84. University of California – Berkeley, Dept. of Chemistry, February 5, 2007. “Chemistry and Biology of Lanthionine Biosynthesis” 83. 20th Enzyme Mechanisms Conference, St. Pete Beach, Florida, January 3-6, 2007.

“Chemistry and Biology of Lanthionine Biosynthesis” 82. Syracuse University, Department of Chemistry, November 14, 2006. “Chemistry and Biology of Lanthionine Biosynthesis” 81. University of Missouri – Columbia, Department of Chemistry, November 10, 2006. “Chemistry and Biology of Lanthionine Biosynthesis” 80. Ohio University (Athens, OH), Dept. of Chemistry, September 25, 2005. “Chemistry and Biology of Lanthionine Biosynthesis” 79. International Symposium on Medicinal Chemistry (ISMC), Istanbul, Turkey August 29-September

2, 2006. “Re-engineering of lantibiotics” 78. Arthur C. Cope Scholar Award address. ACS meeting, San Francisco, August 27-31, 2006. 77. Gordon Research Conference on Bioorganic Chemistry, Oxford, England, July 30-August 4. “Mechanism and application of lantibiotic synthetases” 76. Gordon Research Conference on Biocatalysis, Rhode Island, July 9-14, 2006. “Using lantibioticsynthetases for protein engineering” 76. Utrecht University, Department of Medicinal Chemistry, April 4, 2006 “Synthesis of Peptide Conjugates” 75. Stanford University, Department of Chemistry, February 8, 2006. “Chemistry and Biology of Lanthionine Synthesis” 74. Arizona State University, Department of Chemistry, February 6, 2006. “Post-translational modifications during lantibiotic biosynthesis” 73. GRC, Program-Protein Derived Cofactors Radicals and Quinones, Ventura, CA January 22-27,

2006. “Post-translational modifications during lantibiotic biosynthesis” 72. Pacifichem, Honolulu, Hawaii, December 15-20, 2005. “Mechanistic aspects of chlorinated ethylene degradation by vitamin B12” 71. Pacifichem, Honolulu, Hawaii, December 15-20, 2005.

Page 33: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

33

“The structure of radical intermediates in lipoxygenase and cyclooxygenase” 70. ACS National Meeting, Washington, D.C., August 28-September 1, 2005. Symposium: Strategies

and Molecular Mechanisms of Contaminant Degradation Chemistry. 69. GRC, Enzymes, Coenzymes, and Metabolic Pathways, Meriden, NH, July 17-22, 2005. “Post-translational modifications during lantibiotic biosynthesis” 68. 19th American Peptide Symposium, San Diego, June 18-26, 2005. “Post-translational modifications during lantibiotic biosynthesis” 66. Baker Symposium on Chemical Biology, Dept. of Chemistry and Chemical Biology, Cornell

University, April 30, 2005. “Post-translational modifications during lantibiotic biosynthesis” 65. ASBMB Meeting, San Diego, April 3-7, 2005. “Mechanistic studies on cyclooxygenase and lipoxygenase” 64. Leveraging Natural Products for Drug Development, Conference, Crown Plaza Hotel,

Philadelphia, February 28- March 1, 2005. “Combinatorial Biosynthesis of Lantibiotics and Its Role in the Development of New Chemical

Tools” 63. Harvard University, Dept. of Chemistry, February 28, 2005. “Semisynthesis of Post-Translationally Modified Antibiotics” 62. Olivet Nazarene University, Dept. of Chemistry, Kankakee, IL, February 4, 2005. “Chemistry and Biology of Antibiotics” 61. NRSCC / NIOK conference, January 5-7 2005. Noordwijkerhout, The Netherlands. “Post-translational modifications during lantibiotic biosynthesis” 60. Universiteit Groningen, The Netherlands, January 4, 2005. “Post-translational modifications during lantibiotic biosynthesis” 59. Pfizer Award Lecture, ACS National Meeting, Philadelphia, August 22-26, 2004. “Biosynthesis of Lantibiotics” 58. Science@theInterface Conference, University of Chicago, June 3, 2004. “Engineering of the Biosynthesis of Post-translationally modified peptide antibiotics” 57. Boston College, Department of Chemistry, May 12, 2003. “Post-translational Modifications during Lantibiotic Biosynthesis” 56. Vrije Universiteit Amsterdam, April 20, 2004. “Exercises in understanding enzyme mechanisms: cyclooxygenase and phosphite dehydrogenase” 55. Leiden University, Department of Chemistry, The Netherlands, April 19, 2004. “Mechanistic Studies on the Vitamin B12 Catalyzed Dechlorination of Perchloroethylene” 54. 17th Wageningen Symposium on Organic Chemistry, Wageningen, The Netherlands, April 15-16,

2004. “Chemical and Enzymatic Studies on Lanthionine Formation” 53. Washington State, Department of Chemistry, March 29, 2004. “Engineering of Antibiotic Biosynthesis” 52. UPenn, Department of Chemistry, Philadelphia, March 25, 2004. “Engineering of Antibiotic Biosynthesis” 51. University of Michigan, Ann Arbor, March 22, 2004. “Engineering of Antibiotic Biosynthesis” 50. Isotopes Gordon Research Conference, Ventura, February 15-19, 2004. “An unusual isotope effect on substrate inhibition in lipoxygenase” 49. University of Texas Health Science Center, Houston, Dept. of Biochemistry, January 12, 2004.

“Posttranslational Modifications Involved in Lantibiotic Biosynthesis”

Page 34: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

34

48. University of Alberta, Dept. of Chemistry, Edmonton, October 3, 2003. “Chemical and Enzymatic Studies on Lanthionine Formation” 47. Vitamin B12 Gordon Research conference, Colby College, Waterville, ME. July 6-10, 2003.

“Mechanistic Studies on the Vitamin B12 Catalyzed Dechlorination of Perchloroethylene” 46. University of Illinois at Chicago, Dept. of Chemistry, March 18, 2003. “Radical chemistry in cyclooxygenase and lipoxygenase” 45. Johns Hopkins University, Dept. of Chemistry, Baltimore. March 4, 2003. “Mechanistic studies on the vitamin B12 catalyzed dechlorination of perchloroethylene” 44. Vanderbilt University, Toxicology seminar, Nashville. November 8, 2002. “Mechanistic Studies on Prostaglandin Synthase and Lipoxygenase” 43. Oregon Graduate Institute, Dept. of Biochemistry, Portland, November 1, 2002. “Radical intermediates in cyclooxygenase catalysis” 42. University of Texas Southwestern, Dept. of Biochemistry, Dallas, October 24, 2002.

“Identification of Radical Intermediates in Prostaglandin H Synthase” 41. University of Wisconsin, Madison, September 27, 2002. “Isotopically Labeled Arachidonic Acids for the Study of Prostaglandin Synthase and

Lipoxygenase” 40. 3M Company, St Paul, Minnesota, June 3, 2002. “Synthesis and applications of isotopically labeled arachidonic acids for the study of

cyclooxygenase” 39. Invited speaker, 34th Great Lakes Regional Meeting, Minneapolis, Minnesota. June 4, 2002. “Phosphite Dehydrogenase, an Unusual PhosphorylTransferase” 38. Invited speaker, 34th Great Lakes Regional Meeting, Minneapolis, Minnesota. June 2, 2002.

“Mechanistic studies on vitamin B12-catalyzed dechlorination of perchloroethylene” 37. Stanford University, May 29, 2002. “Synthesis of isotopically labeled arachidonic acids for the study of cyclooxygenase” 36. MIT, Dept. of Chemistry, April 29, 2002. “Radically Different Enzymes: Cyclooxygenase, Lipoxygenase, and Cytochrome c Oxidase” 35. Notre Dame University, Dept. of Chemistry, March 20, 2002. “Identification of Radical Intermediates in Cyclooxygenase” 34. University of California at San Diego, Dept. of Chemistry, March 18, 2002. “Mechanistic Studies on the Vitamin B12 Catalyzed Dechlorination of Chloroalkene Priority

Pollutants” 33. Scripps Research Institute, March 15, 2002. “Radically Different Enzymes: Cyclooxygenase, Lipoxygenase, and Cytochrome c Oxidase” 32. University of Delaware, Dept. of Biochemistry, February 11, 2002. “Exercises in Understanding Enzyme Mechanisms: Cyclooxygenase and Azurin” 31. Duke University, Dept. of Biochemistry, February 8, 2002. “Exercises in Understanding Enzyme Mechanisms: Cyclooxygenase and Azurin” 30. Ohio State University, Dept. Chemistry, Columbus, OH, January 31, 2002. “Identification of Radical Intermediates in Cyclooxygenase” 29. University of Michigan, Pfizer seminar in Medicinal Chemistry, January 24, 2002. “Identification of Radical Intermediates in Cyclooxygenase” 28. Gordon Research Conference “Quinone and Amino Acid Radical Cofactors” January 13-18, 2002.

Ventura, California. “Identification of Radical Intermediates in Prostaglandin Synthase” 27. Rice University, Dept. of Chemistry, Houston, TX, November 30, 2001. “Vitamin B12 as Remediation Catalyst for Dehalogenation of Priority Pollutants”

Page 35: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

35

26. Texas A&M University, Dept. of Chemistry, College Station, November 29, 2001. “Exercises in enzyme mechanisms: cyclooxygenase and azurin” 25. University of Texas, Dept. of Chemistry, Austin, November 28, 2001. “Exercises in enzyme catalysis: phosphite dehydrogenase and azurin” 24. Colorado State University, Dept. of Chemistry, Fort Collins, Colorado, Oct. 23, 2001. “Vitamin B12 as Remediation Catalyst for Dehalogenation of Priority Pollutants” 23. Brigham Young University, Dept. Chemistry, Provo Utah, October 19, 2001. “Exercises in understanding enzyme mechanisms: cyclooxygenase and phosphite dehydrogenase” 22. University of Utah, Dept. Chemistry, October 18, 2001. “Characterization of an Arachidonyl Radical during COX-2 Catalysis” 21. SUNY Stony Brook, Dept. of Chemistry, October 11, 2001. “Characterization of an Arachidonyl Radical during COX-2 Catalysis” 20. 4th Annual Chinese-American Frontier of Science Symposium, sponsored by the National

Academy of Sciences, Beijing, China, September 21-23, 2001, 2001. 19. Peking University, Department of Chemistry, Beijing, China, September 18, 2001.

“Understanding and manipulating enzymes using organic chemistry: prostaglandin synthase and azurin”

18. 222nd ACS National Meeting, Chicago. August 26-30, 2001. Invited Speaker for Symposium: “The Future is Now.” Organized by John Schwab, NIGMS.

17. Burroughs-Wellcome Fund New Investigators Meeting, San Diego, July 27-29, 2001. “The Biosynthesis of Lantibiotics” (poster) 16. Bioorganic Gordon Research Conference, Andover, NH, June 17-21, 2001. “Radical Intermediates in Enzyme Catalysis” 15. Johnson Foundation Discussions, “40 Years of Tunneling in Biology.” UPenn, May 2-5, 2001.

“Hydrogen Atom Transfer in Prostaglandin H Synthase” 14. UCLA, Dept. Chemistry, April 26, 2001. “Formation of a Pentadienyl Radical during COX-2 Catalysis” 13. Washington University, St. Louis, Dept. Chemistry, April 24, 2001.

“Mechanistic Studies on Vitamin B12-catalyzed dehalogenation of priority pollutants” 12. Columbia University, Dept.. Chemistry, February 8, 2001. “Mechanistic Studies on Vitamin B12-

catalyzed dehalogenation of chlorinated alkenes.” 11. Northwestern University, Dept. Chemistry, January 25, 2001. “Mechanistic Studies on Vitamin B12-catalyzed dehalogenation of chlorinated alkenes” 10. 17th Enzyme Mechanisms Conference, January 3-6, 2001, Marco Island, Florida. “Identification of a pentadienyl radical during COX-2 catalysis.” Poster selected for Oral

Presentation (4 out of 110 posters selected). 9. Baylor College of Medicine, Dept. of Biochemistry and Molecular Biology, Houston, TX,

November, 30, 2000. “Phosphite Dehydrogenase, an Unusual Phosphoryl Transfer Reaction” 8. Rose Hulman Institute, Dept. of Chemistry, October 26, 2000. “Mechanistic Studies on Vitamin B12 Catalyzed Dechlorination of Organic Pollutants” 7. 5th European Symposium on Vitamin B12 and B12-Proteins, Marburg, Germany, September 10-15,

2000. “Mechanistic Studies on Vitamin B12-Catalyzed Dechlorination of Chlorinated Alkenes” 6. 20th Midwest Enzyme Chemistry Conference, University of Chicago, September 23, 2000.

“Phosphite Dehydrogenase: an Unusual Phosphoryl Transfer Reaction” 5. Beckman Symposium, Beckman Institute, University of California, Irvine, August 25-26, 2000.

“Exploring the Post-Translational Modifications of Lantibiotics”

Page 36: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

36

4. 220th ACS National Meeting August 20-24, 2000, Washington, D.C. “Mechanistic Studies on Vitamin B12-Catalyzed Dechlorination of Chlorinated Alkenes” 3. Enzyme Mechanisms Gordon conference, Meriden, New Hampshire, July 16-20, 2000.

“Phosphite Dehydrogenase: an Unusual Phosphoryl Transfer Reaction” (poster) 2. NSF Workshop on Physical Organic Chemistry, Warner Springs Ranch, California, June 24-27,

2000. “Vitamin B12-Catalyzed Dechlorination of Perchloroethylene” 1. Bioorganic Chemistry Gordon Conference, Andover, New Hampshire, June 18-22, 2000.

“Synthesis of Isotopically Labeled Arachidonic Acids for Mechanistic Studies of Prostaglandin Synthase”

GRADUATE STUDENTS SUPERVISED

NAME DATE PROGRAM POSITION UPON

GRADUATION/CURRENT

1 Nicole M. Okeley 1997-May 2002, Ph. D. Org. Chem. Postdoc Michael Gelb Now Seattle Genetics

2 Jennifer M. Vrtis 1997-June 2002, Ph. D. Org. Chem. Abbvie 3 Hao Zhou 1997-August 2002, Ph. D. Org. Chem. Postdoc James Cook

Now Lundbeck Pharma.4 Justin Shey 1997-August 2002, Ph. D. Org. Chem. USDA, Albany CA

Now Customs & Border Protection Lab, San FranciscoCA

5 Matt D. Gieselman 1998-August 2003, Ph. D. Org. Chem. Lubrizol

6 Kevin M. McCauley 1998-May 2003, Ph.D. Org. Chem. Postdoc Greg Fu, MIT Now Saint-Gobain Performance Plastics

7 Lili Xie 1998-Sept. 2003, Ph. D. Org. Chem. Postdoc J. Clardy, Harvard Now Novartis

8 Yantao Zhu 1998-June 2003, Ph.D. Org. Chem. General Electric Now SABIC, Mount Vernon, IN

9 Russell P. Pesavento 1999-August 2004, Ph.D. Inorg. Chem. Postdoc R. Holm, Harvard; Attorney, Sterne, Kessler, Goldstein & Fox; Dental School, U. Iowa Now: Visiting Scientist, U. Illinois Chicago College of Dentistry and Associate Dentist at Dr. Ginger Christian & Associates

10 Champak Chatterjee 1999-2005, Ph. D. Chem. Biol. Postdoc T. Muir, RockefellerNow Associate Prof. U. Washington

1a Erin Criswell 1999-2001, M.S. Org. Chem. Tate & Lyle, Decatur, IL Now E Ink Corp

Page 37: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

37

11 Moushumi Paul 1999-2005, Ph.D. Org. Chem. Postdoc R. Raines, U. Wisconsin Now USDA, Philadelphia

2a Joshua Wheatley 2000-2003, M.S. Biochem. ADM

3a Wesley Swanson 2000-2003, M.S. Org. Chem. Polaris Laboratories Now Pfizer

12 Christopher McGinley 2000-2005, Ph. D. Org. Chem. Hospira Pharmaceuticals Now CareFusion

13 Danica Galonic Fujimori1 2000-2005, Ph. D. Org. Chem. Postdoc C. Walsh, Harvard Medical School Now Associate Prof. UCSF

14 Ryan Woodyer2 2001-2005, Ph. D. Chem. Biol. ZuChem, Peoria Tate & Lyle, Decatur Now Coca Cola, Atlanta

15 Heather Relyea 2001-2006, Ph.D. Org. Chem. Postdoc Tom O’Halloran Now Dow Biocides

16 Cyril Jacquot 2002-2008, Ph.D. 2011 M.D.

Org. Chem. Pathology Residency, UCSF Now Children's National Health System

4a Chris Kerwood 2003-2007, M.S. Chem. Biol. Tate & Lyle, Decatur, IL17 Gregory Patton 2003-2008, Ph.D. Org. Chem. Postdoc L. Hedstrom, Brandei

Now New England Biolabs18 Matt Levengood 2003-2008, Ph.D. Chem. Biol. Postdoc L. Kiessling,

U. Wisconsin Now Seattle Genetics

19 Young Ok You 2003-2008, Ph.D. Biochemistry Postdoc David Cane, Brown U. Now Asst Prof George Mason U.

20 Leigh Anne Furgerson 2004-2009, Ph.D. Org. Chem. Postdoc Dale Poulter Now GlaxoSmithKline

21

Jin-Hee Lee

2004-2010, Ph.D.

Org. Chem.

Postdoc John Denu, U. Wisconsin–Madison Now Pharmaceutical Product Development Inc, Madison

22 Lisa Cooper 2004-2009, Ph.D. Biochemistry Postdoc Tadgh Begley, Texas A&M Now Dow Microbial Control

23 Kevin Clark3 2004-2010, Ph.D. J.D.

Biochemistry Franklin Pierce Law School Now Patent Counsel at Genentech

24 Bo Li 2004-2009, Ph.D. Biochemistry Postdoc C. Walsh, Harvard Medical School Now Asst Prof UNC Chapel Hill

Page 38: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

38

5a Abdul Gabisi 2004-2007, M.S. Biochemistry Researcher M.D. Anderson, Houston

25 Ian Gut4 2005-2011, Ph.D. Microbiology Postdoc US Army Now PI, Battelle National Biodefense Institute

26 John Whitteck 2005-2010, Ph.D. Org. Chem. New Leaf Symbiotics27 Trent Oman 2006-2011, Ph.D. Chem. Biol. Eli Lilly 28 Juan Velásquez 2006-2011, Ph.D. Chem. Biol. Procter & Gamble6a Lindsey Johnstone Shea 2007-2011, M.S.

2015, M.D. Chem. Biol. Medical School, UIUC

Now Resident, Indiana University School of Medicine

7a Isabel Neacato 2010-2012, M.S. 2014, M.D.

Microbiology Medical School, UIUC Now Resident, Beaumont Health, Royal Oak, Michigan

8a Tong Hee Koh 2009-2012, M.S. Biochemistry Hanmi Pharmaceutical, S. Korea

29 Patrick Knerr 2008-2013, Ph.D. Chem. Biol. DuPont Crop Protection Now Novo Nordisk

30 Neha Garg5 2008-2013, Ph.D. Biochemistry Postdoc P. Dorrestein, Skaggs School of Pharmacy Now Asst Prof Georgia Tech

31 John Hung

2008-2013, Ph.D. Chem. Biol. Sigma-Aldrich Now Amyris

32 Yanxiang (Nancy) Shi 2008-2013, Ph.D. Chem. Biol. Syngenta Crop Protection33 Noah Bindman 2008-2013, Ph.D Chem. Biol. Seattle Genetics34 Ayse Okesli 2008-2014, Ph.D. Chem. Biol. Postdoc C. Khosla, Stanford

Now Gilead, CA35 Spencer Peck 2009-2014, Ph.D. Chem. Biol. Postdoc E. Balskus, Harvard

Now Kintai Therapeutics, MA36 Min Zeng6 2008-2015, Ph.D. Cell Biol. Lecturer Indiana U. – Purdue

Now Data Analyst, AIDS Healthcare Foundation

37 Yi Yu 2009-2015, Ph.D. Biochemistry Postdoc Huimin Zhao Now Beam Therapeutics, MA

38 Weixin Tang 2009-2015, Ph.D. Chem. Biol. Postdoc David Liu, Harvard Fall 2019 Asst Prof U Chicago

39 Xiao Yang 2009-2015, Ph.D. Chem. Biol. Radiant Genomics, CA Now Zymergen, CA

40 Chantal Garcia De Gonzalo 2010-2015, Ph.D. Chem. Biol. Amyris, CA

41 Subha Mukherjee 2010-2015, Ph.D. Chem. Biol. Bristol-Myers-Squib42 Manuel Ortega 2010-2015, Ph.D. Biochemistry Postdoc C. Drennan, MIT 43 Xiling Zhao 2011-2017, Ph.D. Chem. Biol. Amyris, CA44 Nidhi Kakkar 2012-2018, Ph.D. Chem. Biol. Intel, Portland OR45 Emily Ulrich 2012-2018, Ph.D. Chem. Biol. Postdoc C. Drennan, MIT Joshua Wagoner 2012-2015 Chem. Biol. Not known

Page 39: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

39

46 Kenton Hetrick 2013-2018, Ph.D. Chem. Biol. Postdoc R. Raines, MIT47 Kwo-Kwang (Abe) Wang 2013-2018, Ph.D. Chem. Biol. Postdoc L. Nolan, MIT48 Zhengan Zhang 2013-2018, Ph.D. Chem. Biol. Postdoc C. Voigt, MIT Silvia Bobeica 2013-present Org. Chem Linna An 2014-present Chem. Biol. Subhanip Biswas 2014-present Org. Chem Kuan-Yu (Nick) Lai 2014-present Biochemistry Chang He 2014-present Chem. Biol. 9a Marc Gancayco 2015-2018, M.S. Chem. Biol. Not known Martin McLaughlin 2015-present Chem. Biol. Max Simon 2016-present BioE Imran Rahman 2016-present Biochemistry Page Daniels 2017-present Biochemistry Tung Le 2017-present Chem. Biol. Chunyu (Layla) Wu

Emily Desormeaux Sara Eslami Dinh Nguyen7

Raymond Sarksian Haoqian (Lainey) Liang

2017-present 2018-present 2018-present 2018-present 2018-present 2018-present

Biochemistry Chem. Biol. Chem. Biol. Chem. Biol. Org. Chem Biochemistry

a Masters of Science. All others PhD. 1Supervised jointly with David Y. Gin. 2 Supervised jointly with Huimin Zhao (Chem E). 3 Supervised jointly with Yi Lu. 4Supervised jointly with Stephen Blanke (Microbiology).5Supervised jointly with Satish Nair (Biochemistry).6Supervised jointly with Jie Chen (Cell and Developmental Biology). 7Supervised jointly with Douglas Mitchell. Underlined: underrepresented minority student POSTDOCTORAL ASSOCIATES SUPERVISED NAME DATE GRADUATE

INSTITUTION

POSITION UPON LEAVING

UIUC1 Rashna Balsara 1998-2002 BARC1 Postdoc Victoria Ploplis

Now Research Assoc. Prof. Notre Dame

2 Sheng Peng 1999-2003 SIOC2 Dupont

3 Xingang Zhang 2003-2007 SIOC2 Professor Shanghai Institute of Organic Chemistry

4 Derek Pratt 2003-2005 Vanderbilt Prof. U of Ottawa, Canada5 Michelle Ni 2004-2006 NC State W.R. Grace 6 Gongyong Li 2005-2007 SIOC2 Shanghai Chemspec

Corporation 7 Amanda McClerren 2005-2007 Duke University Monsanto Corporation8 Emily Fogle 2005-2007 UC Davis Assoc Professor, California

Polytechnical – San Luis Obispo

9 Robert Cicchillo 2006-2008 Penn State Research Scientist – Dow, Indianapolis, IN

10 Svetlana Borisova 2007-2011 UT Austin Amyris, Emeryville, CA

Page 40: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

40

(joint w/ W. Metcalf) 11 Yuki Goto 2008-2009 U Tokyo Associate Professor, U.

Tokyo12 Nicholas Llewellyn 2008-2009 U Cambridge, UK Lecturer, Chemistry, Emory13 Remco Merkx 2008-2009 Utrecht University

The NetherlandsNetherlands Cancer Institute

14 Seung-Young Kim 2009-2011 University of Tokyo Asst. Professor, Sun Moon U., Korea

15 Michael Kuemin 2009-2010 University of Basel, Switzerland

Bachem, Bubendorf, Switzerland

16 Heather Cooke 2009-2011 Boston College Biogen 17 Huan Wang 2010-2013 U of Maryland Asst. Prof. Nanjing U.18 Gabrielle Thibodeaux 2010-2016 UT Austin Research Asst. McGill U.19 Despina Bougioukou 2010-2013 U of Florida DuPont, Wilmington, DE20 Jiangtao Gao 2010-2014 U Mississippi Prof. Fujian Agriculture and

Forestry University 21 Qi Zhang 2011-2014 SIOC2 Asst. Prof. Fudan U.22 Ran Zhang 2011-2012 U British Columbia Lecturer UBC-Okanagan23 Rebecca Splain 2011-2014 U Wisconsin GlaxoSmithKline 24 Zedu Huang 2012-2016 U Alberta Asst. Prof. Fudan U.25 Debapriya Dutta 2012-2018 U Florida

GainesvillePostdoc w/ Shuming Nie, U. Illinois

26 Christopher Thibodeaux (joint w/ TJ Ha)

2012-2016 UT Austin Asst. Prof. McGill U.

27 Mark Walker 2013-2018 UC Berkeley Asst. Prof. U. New Mexico28 Lindsay Repka 2013-2017 Caltech Asst. Prof. Middlebury

College, Vermont 29 Liujie Huo 2014-2017 U Saarland,

GermanyAsst. Prof. Shandong U.

30 Ian Bothwell 2015-present Memorial Sloan-Kettering

31 Michael Funk 2015-2017 MIT Associate Editor, Science32 Julian Hegemann 2016-2019 University of

Marburg, GermanyPostdoc w/ Roderich Süssmuth, TU Berlin

33 Graeme Howe 2016-2019 University of Toronto

Asst Prof. Queen’s University, Canada

34 Chi Ting 2017-present UC Berkeley35 Jeella Acedo 2018-present University of

AlbertaAsst Prof. Mount Royal University, Calgary, CA

36 37

David Krist Daisuke Fujinami

2018-present 2019-present

Northwestern University Kyushu University

1Bhabha Atomic Research Center 2 Shanghai Institute of Organic Chemistry

Page 41: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

41

UNDERGRADUATE STUDENTS SUPERVISED Students listed in italics font are authors on papers NAME DATES PROGRAM1 INSTITUTION POSITION UPON

LEAVING UIUC1 Joseph Dupont2 Summer 1999

Snyder fellowSophomore Chemistry

Worcester Polytech

Continue BS in Worcester

2 Rohini Madigalker Spring & Summer 1999 Sophomore Chem. Eng.

UIUC unknown

3 Anthony Dearth Summer & Fall 2000 Freshman Chem. Eng.

UIUC Equistar Inc.

4 Brian Young Spring 2000-Spring 2001 Junior Chemistry

UIUC Graduate School Case Western

5 Mandy Chan Summer 2000-Spring 2001 Senior Chemistry

UIUC Cabrillo Labs San Diego

6 Leah Smith3 Summer 2000 (HURF)3 Freshman Biology

Howard Univ. Pharmacy School U. Illinois, Chicago

7 Aaron Wilson Summer 2000-Spring 2002 Junior Chemistry

UIUC Magn. Reson. Microsensors Corp.

8 Stacey Rimkus Fall 2000-Spring 2002 Junior Cell, Struct. Biol.

UIUC Graduate School U. Wisconsin

9 Meera Raja Summer 2001-present Junior Chemistry

UIUC Graduate School Northwestern U.

10 Carol Guerra3 Summer 2002-Spring 2003

Sophomore, Biochemistry

UIUC Left UIUC before graduating

11 Katrina de Ocampo3

Summer 2002-2003 Senior Chemistry

UIUC Abbott Labs

12 Monica Shete Summer 2002-2005 (HURF)3

Freshman Biology

UIUC Med School

13 Eric Bunnelle Fall 2003-Spring 2004 Sophomore Chemistry

UIUC Graduate School UC Berkeley

14 Phillip Stewart- Hutchinson

Summer 2003-2005 Junior Chemistry

UIUC Graduate School NYU

15 Jerry Jeffers Summer 2003-Summer 2004

Junior Chemistry

UIUC deceased while at UIUC

16 Bryan Prendergast Summer 2003-2005 Junior Chemistry

UIUC Medical School

17 Juyoung Jang Summer 2003-2005 Sophomore Biochemistry

UIUC NIH

18 Yong Leung Summer 2003-2005 Junior Chemistry

UIUC

19 Katie Peterson Summer 2004 Snyder fellow

Junior Chemistry

Illinois Wesleyan

Graduate School Indiana U.

20 Akinola Soyode-Johnson3

Summer 2004-2006 Sophomore Chemistry

UIUC Johnson & Johnson Pharmaceutical Research & Development, La Jolla, CA

Page 42: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

42

21 Daniel Delacruz3 Summer 2004-2006 Freshman Chemistry

UIUC Kraft Inc

22 Erik Plata3 Summer 2005 Junior Chemistry

TAMU Kingsville

Now: Asst. Prof., U. Texas Rio Grande Valley Postdoc w/ Donna Blackmond, Scripps PhD, Chemistry, Texas A&M w/ Daniel Singleton

23 Nicole Andrusevich3

Summer 2006 Sophomore Chemistry

UIUC Nursing School

24 Justin Poole3 Summer 2006-Spring 2007 Freshman Chemistry

UIUC Med School, UIC

25 Gabe Hintzsche Summer 2006-Spring 2008 Sophomore Chemistry

UIUC Med School, Mid-western U, Glendale, AZ

26 Jose Israel Armendariz Guajardo3

Summer 2006 Sophomore ITSM, Monterrey Mexico

27 Jennifer Palow Summer 2007 Junior UConn Graduate School Boston College

28 Anita Chary Summer 2006-Spring 2008 UIUC Teacher in Guatemala entered WUSTL MD/PhD program in Fall ‘09

29 Brittney Cole3 Fall 2007-Dec 2008 Junior UIUC MS program Biotechnology, Rush University

30 Michael Jellinek Spring 2007-2009 Sophomore Biochemistry

UIUC Rush Medical School, Chicago

31 Shelly Lim Spring 2007-2009 Sophomore Biochemistry

UIUC PhD from Princeton; postdoc in X. Zhao lab, Memorial Sloan Kettering; now medical writer at ICON

32 Luis Negron3 Summer 2007 Sophomore University of Puerto Rico at Rio Piedras

PhD, U. Puerto Rico, Río Piedras; now Lilly del Caribe at Carolina

33 Daniela Irma Herrera3

Summer 2008 Sophomore ITSM, Monterrey Mexico

Page 43: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

43

34 Robert Koehler3 Summer 2008 Summer 2009

Sophomore Junior, Biology

San Diego State

Graduated with BS 2011

35 Myrna Rivas3 Summer 2009 Junior, Chemistry UIUC Graduated with BS, 2011

36 Xenia Okalibe3 Summer 2009 Sophomore, pre-Pharmacy

U Michigan Pharmacy School

37 Steven Martinez3 Summer 2009 Junior, Chemistry Cal State Univ, Dominguez Hills

Graduate School, UC Santa Barbara

38 Amanda Brunner Spring 2009-2011 Sophomore Biology

UIUC Medical School

39 Claire Creed Spring 2009-2011 Sophomore Biology

UIUC Medical School

40 Victor Garcia-Lopez3

Summer 2010 Junior, Chemistry ITESM Graduate School, Rice University

41 Kwadwo (Kojo) Opoku-Nsiah3

Summer 2010 Senior, Chemistry Colby College Pharmacy School

42 Nicholas Herrman Summer 2010 Junior, Chemistry Albion College Med School43 Alejandro Bueno3 Fall 2010-Spring 2013 Sophomore UIUC North Shore Center

for Medical Aesthetics

44 Vanessa Nepomuceno3

Summer 2010 Chemistry, Rising Senior

South Carolina State Univ.

Graduate School UIC Dept Med Chem & Pharmacognosy

45 Candace Wong Spring 2011-Spring 2014 Freshman, MCB UIUC Graduate School Toxicology, U. Rochester

46 Nejmun Hussain5 Fall 2011-2012 Junior, MCB UIUC

47 Michael Celestine3 Summer 2010 & 2011 Chemistry, Rising Senior

Univ. of the Virgin Islands

Graduate School, Old Dominion University

48 Ting Chen Spring 2012-Spring 2013 Junior, Chemistry UIUC Graduate School, Nursing & Public Health, Columbia University

49 Yunli Ma Spring 2012-Spring 2013 Junior, Biochemistry

UIUC Graduate School, Northwestern

50 Tia Harper Spring 2012-Spring 2013 Sophomore, Chemical Engineering

UIUC Transferred to Kansas State

51 Megan Dudek Summer 2012 Senior, Biochem./Mol Biology

U. Wisconsin-Eau Claire

52 Rachel Joyce Summer 2012-Spring 2014 Junior, Molecular & Cell Biology

UIUC Graduate school, LSU, Biology

Page 44: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

44

53 Yunhong Wang Fall 2012- Spring 2015 Sophomore, Biochemistry

UIUC MS Bioengineering Johns Hopkins

54 Dhruv Kumar Fall 2012- Spring 2014 Sophomore, Molecular & Cell Biology

UIUC Research assistant, UC Berkeley

55 Katarzyna Dubiel Fall 2012- Spring 2014 Junior, Molecular & Cell Biology

UIUC Graduate school UW Madison, Integrated Biochemistry

56 Bryan Schaeffer Spring 2013-Spring 2015 Freshman, Biology

UIUC

57 Kyle Ridlen Spring 2014-Spring 2015 Junior, Molecular & Cell Biology

UIUC Graduate school, Indiana University-Purdue University, Indianapolis, Physiology

58 Rigoberto Hernandez Cervantes3

Summer 2014 Junior Indiana University

59 Marc Gancayco3 Summer 2014 Junior San Jose State University

Graduate school, UIUC

60 Aaron Briggs3,4 Summer 2014 Senior Dartmouth Med School, Dartmouth

61 Shivaliben Patel Spring 2015-Spring 2016 Sophomore, Molecular & Cell Biology

UIUC

62 See Hyun “Anna” Chee

Spring 2015-Fall 2016 Sophomore, Chemical Engineering

UIUC

63 Kyle McKillop Spring 2015-Fall 2016 Freshman, Chemistry

UIUC

64 Zack Foust Spring 2015-Spring 2016 Sophomore, Molecular & Cell Biology

UIUC

65 Shan Huang Summer 2015 Junior, Chemistry Fudan University

Graduate school, Caltech, S. Mayo lab

66 Sarah Ackenhusen Fall 2015-Summer 2018 Sophomore, Chemistry

UIUC Graduate school, U Michigan-Ann Arbor

67 Mary Hwang Fall 2015-Spring 2016 Sophomore, Molecular & Cell Biology

UIUC

68 Anjelica Kokinias Spring 2016-Spring 2017 Sophomore, Molecular & Cell Biology

UIUC Nursing School

Page 45: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

45

69 Terry Kim Spring 2016-Summer 2018 Sophomore, Molecular & Cell Biology

UIUC Graduate school, Caltech

70 Yery Kim Summer 2017-Spring 2018 Senior, Chemistry UIUC 71 Zhe Li Summer 2017-Fall 2018 Junior, Chemistry UIUC 72 Alexander Pilski Spring 2017-Fall 2018 Junior, Chemistry UIUC Applying to

Graduate school73 Yuanheng “Henry”

Wang Summer 2017-Fall 2017 Junior, Chemistry UIUC Graduate school,

Stanford74 Audrey Rex Summer 2017 Junior Eastern Illinois

University Graduate school, University of Georgia

75 Jonathan Gong Spring 2018-Fall 2018 Freshman, ChBE UIUC 76 William Farrell Summer 2018 Junior, Molecular

& Cell BiologyUIUC

77 Clara Frazier Summer 2018 Senior, Biochemistry & Animal & Poultry Science

Virginia Tech Graduate school, Integrated Program in Biochemistry, U. Wisconsin, Madison

78 Abby Trouth Summer 2018 Junior, Biochem & Molecular Biology

Gustavus Adolphus College

Goldwater Scholar

79 Autumn King Fall 2018-present Junior, Chemistry UIUC 80 Alondra Sanchez3 Fall 2018-present Junior, Chemistry UIUC 81 82

Margo van Loon Lark Moreno3

Fall 2018 Spring 2019-present

Junior, Chemistry Sophomore, ChBE

UIUC UIUC

83 Ramiro Alvarado3 Summer 2019 Freshman, Chemistry

UIUC

84 David Qiu Summer 2019 Junior, Chemistry Vanderbilt 1 Academic status and major of the student at the time of joining the laboratory 2 Nineteen students, listed in italics, are co-authors on research papers in the period 2000-present 3 Twenty-seven underrepresented minority students in the period 2000-present 4 HURF = Howard Hughes Undergraduate Research Fellowship Program 5 Adjunct advisor for Anne Baranger student after Anne left UIUC At least 41 students went on to Graduate School (26), Medical School (9), Pharmacy School (3), or Nursing School (3). For many summer experience students from other institutions, it is not known to us what careers they pursued. EDUCATIONAL ACTIVITIES COURSE LEVEL DATE Chemistry Laboratory 1 freshman Fall 1997 Introduction to Organic Chemistry Research graduate Spring 1998 Advanced Physical Organic Chemistry senior/graduate Fall 1998 Organic Chemistry Seminar graduate Spring 1999 Advanced Physical Organic Chemistry senior/graduate Fall 1999 Enzyme Reaction Mechanisms and Drug Target Interactions graduate Spring 2000

Page 46: WILFRED A. VAN DER DONK University of Illinois at Urbana ...vanderdonk.scs.illinois.edu/wp-content/uploads/... · John Daly lecture, National Institutes of Health, October 26, 2018

46

Advanced Physical Organic Chemistry senior/graduate Fall 2000 Structure and Synthesis Laboratory sophomore Fall 2001 Enzyme Reaction Mechanisms and Drug Target Interactions graduate Spring 2002 Structure and Synthesis Laboratory sophomore Fall 2002 Advanced Physical Organic Chemistry senior/graduate Fall 2003 Enzyme Reaction Mechanisms and Drug Target Interactions graduate Spring 2004 Introduction to Organic Chemistry sophomore Fall 2004 Structure and Synthesis Laboratory sophomore Spring 2005 Introduction to Organic Chemistry sophomore Fall 2005 Chemical Biology Laboratory senior/graduate Spring 2007 Organic Chemistry Seminar graduate Fall 2007 Enzyme Reaction Mechanisms and Drug Target Interactions senior/graduate Spring 2008 Chemical Biology Laboratory senior/graduate Spring 2008 Introduction to Organic Chemistry sophomore Fall 2008 Chemical Biology Laboratory senior/graduate Spring 2009 Chemical Biology Seminar graduate Fall 2010 Physical Organic Chemistry graduate Fall 2011 Physical Organic Chemistry graduate Fall 2012 Physical Organic Chemistry graduate Fall 2013 Structure and Synthesis Laboratory sophomore Spring 2016 Structure and Synthesis Laboratory sophomore Spring 2017 Structure and Synthesis Laboratory sophomore Spring 2018 Structure and Synthesis Laboratory sophomore Spring 2019 Advanced Physical Organic Chemistry senior/graduate Fall 2019 Average student evaluations 1997-2015: 4.4 out of 5.0. UNDERREPRESENTED MINORITY STUDENT MENTORING Started exchange program with Texas A&M Kingsville’s Bridges to Doctorate program Involved in outreach activities as Director of the Chemistry-Biology Interface Training Grant Established SACNAS chapter at UIUC and serves as co-faculty advisor with Prof. Rochelle Gutierrez (Math Education and Latino/Latina Studies) Supervised 24 underrepresented minority undergraduate students, 6 underrepresented minority graduate students, and 1 underrepresented minority postdoc. TEACHING AWARDS Listed in 1998, 1999, 2000, 2003, 2007, and 2018 on the list of “Teachers ranked as excellent by their students” published in the Daily Illini. Results are based on Instructor and Course Evaluation (ICES) questionnaire forms maintained by the university’s Measurement and Evaluation, Center for Innovation in Teaching and Learning and consists of the top 10% of instructors in all disciplines across campus based on student evaluations. 1999 School of Chemical Sciences Teaching Award 2008 School of Chemical Sciences Teaching Award